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1    ABSTRACT 
 
YAP and TAZ, by orchestrating cell proliferation, cell death and cell-fate decisions, 
are key players of a complex network of signaling pathways acting during development. 
Deregulation of YAP/TAZ signaling causes robust organ overgrowth during 
organogenesis, which translates to loss of tissue homeostasis in the adult and 
consequent cancer development. YAP/TAZ are transcriptional co-activators that interact 
with TEAD transcription factors to promote cell proliferation and survival. Their 
transcriptional activity is regulated by nucleocytoplasmic shuttling and nuclear 
accumulation, which are controlled by the Hippo kinase cascade, but also by 
mechanical cues sensed by the cell and by other pathways. Among these, Wnt/β-catenin 
takes on a particular relevance, since it was recently shown to regulate YAP/TAZ 
activity through AXIN-mediated sequestration of YAP/TAZ in the β-catenin destruction 
complex. 
Here, we describe the generation, validation and characterization of a novel 
biosensor zebrafish reporting the activity of Yap/Taz. It expresses nuclear mCherry, 
eGFP or the destabilized green fluorescent protein VenusPEST under the control of a 
promoter fragment of the human YAP/TAZ target gene CTGF, that contains 3 TEAD 
DNA-binding sites. Several independent founder fish transmitting the transgene to the 
germline were identified and used to establish the stable reporter lines. All stable 
transgenic fish shared a similar expression pattern, which was maintained in subsequent 
generations. Knockdown and overexpression approaches were used to validate the 
reporter. Co-injection of two morpholinos targeting Yap and Taz pre-mRNAs reduced 
the reporter signal, whereas injection of mRNAs coding for a constitutively active form 
of Yap, Taz and Tead (YAP-5SA, TAZ-4SA, TEAD-VP16) increased it. The CTGF-
based transgenic lines represent therefore bona fide Yap/Taz reporters. 
During development, strong reporter signal is visible mainly in the lens and otic 
vesicles, the pharyngeal arches, the heart, the pectoral fin and the vasculature, but the 
reporter protein expression is also detected in many other tissues and organs. The 
almost ubiquitous activation of Yap/Taz observed during early embryogenesis, 
consistent with the general role of YAP/TAZ in promoting cell proliferation and organ 
growth, is largely silenced in the adult fish, where the reporter signal is restricted to the 
lens, the ovary, the heart and the whole vasculature. We also showed that the CTGF-
based biosensor zebrafish is able to report Yap/Taz activation during larval and adult fin 
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regeneration, as expected from the role that YAP/TAZ signaling plays in the 
regenerative processes. 
The zebrafish CTGF-based reporter permitted to show in a living organism during 
development the regulation that the Wnt/β-catenin pathway exerts on Yap/Taz activity. 
Our results in terms of variations of the reporter signal, after both genetic and 
pharmacological modulation of the Wnt pathway activity, are in accordance with the 
model recently depicted in vitro. 
The general and sustained reporter activity we observed in the endothelium during 
embryogenesis suggested a functional involvement of Yap/Taz signaling in 
developmental angiogenesis. Yap/Taz knockdown impaired the intersegmental vessels 
(ISVs) growth, while the overactivation of Yap/Taz-mediated transcription caused an 
aberrant sprouting from the ISVs. The vessel sprouting-promoting capacity of Yap/Taz 
is cell-autonomous, as the same phenomenon was observed by expressing TAZ-4SA 
under the control of an endothelium-specific promoter. 
The CTGF-based zebrafish reporter is a new powerful tool to study in vivo Yap/Taz 
pathway activation, with possible applications in drug screening, regeneration and 
cancer biology. It permitted to confirm in vivo during development the crosstalk 
between Wnt/β-catenin and Yap/Taz pathways and to discover a novel role of Yap/Taz 
in vessel sprouting, suggesting a pro-angiogenic function of YAP/TAZ transcriptional 
activity. 
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1    SOMMARIO 
 
YAP e TAZ, orchestrando la proliferazione, la morte e il differenziamento cellulari, 
rappresentano elementi chiave di una complessa rete di vie di segnalazione che 
agiscono durante lo sviluppo. L’alterazione della segnalazione YAP/TAZ causa una 
crescita fuori controllo degli organi durante l’organogenesi, che si traduce nella perdita 
dell’omeostasi tissutale nell’adulto e conseguente sviluppo tumorale. YAP/TAZ sono 
co-attivatori trascrizionali che interagiscono con i fattori di trascrizione TEAD per 
promuovere la proliferazione e la sopravvivenza cellulari. La loro attività trascrizionale 
è regolata dal trasporto nucleo-citoplasmatico e dall’accumulo nucleare, che sono 
controllati dalla cascata chinasica della via di Hippo, ma anche dagli stimoli meccanici 
percepiti dalla cellula e da altre vie. Fra queste, la via di Wnt/β-catenina assume una 
particolare rilevanza, dal momento che è stato recentemente dimostrato che essa regola 
l’attività di YAP/TAZ attraverso il loro sequestro nel complesso di degradazione della 
β-catenina mediato da AXIN. 
In questa tesi vengono descritte la generazione, la validazione e la caratterizzazione 
di un nuovo zebrafish biosensore che riporta l’attività di Yap/Taz. Esso esprime le 
proteine mCherry nucleare, eGFP o la proteina verde fluorescente destabilizzata 
VenusPEST sotto il controllo di un frammento promotoriale del gene umano CTGF 
target di YAP/TAZ, contenente 3 siti di legame per TEAD. Sono stati identificati 
diversi pesci fondatori indipendenti in grado di trasmettere il transgene alla linea 
germinale, i quali sono stati utilizzati per instaurare le linee reporter stabili. Tutti i pesci 
transgenici condividevano un pattern di espressione similare, mantenuto nelle 
generazioni successive. Per validare il reporter sono stati usati approcci di 
downregolazione e overespressione. La co-iniezione di due morfolini diretti contro i 
pre-mRNA di Yap e Taz ha ridotto il segnale reporter, mentre l’iniezione di mRNA 
codificanti per una forma costitutivamente attiva di Yap, Taz o Tead (YAP-5SA, TAZ-
4SA, TEAD-VP16) lo ha aumentato. Le linee transgeniche basate sul gene CTGF 
rappresentano perciò bona fide dei reporter dell’attività di Yap/Taz. 
Durante lo sviluppo, un forte segnale reporter è visibile principalmente nella lente, la 
vescicola otica, gli archi faringei, il cuore, la pinna pettorale e la rete vascolare, ma 
l’espressione della proteina reporter è rilevabile in molti altri tessuti e organi. 
L’attivazione quasi ubiquitaria di Yap/Taz osservata durante l’embriogenesi precoce, 
consistente con il ruolo generale di YAP/TAZ nel promuovere la proliferazione 
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cellulare e la crescita degli organi, è ampiamente silenziata nel pesce adulto, dove il 
segnale reporter è ristretto a lente, ovario, cuore e intera rete vascolare. Lo zebrafish 
biosensore è anche in grado di riportare l’attivazione di Yap/Taz durante la 
rigenerazione della coda nella larva e nell’adulto, come atteso dal ruolo che riveste la 
segnalazione YAP/TAZ nei processi rigenerativi. 
Lo zebrafish reporter basato sul gene CTGF ha permesso di mostrare in un 
organismo vivente durante lo sviluppo la regolazione che la via di Wnt/β-catenina 
esercita sull’attività di Yap/Taz. I nostri risultati in termini di variazione del segnale 
reporter, in seguito alla modulazione genetica e farmacologica dell’attività della via di 
Wnt, sono in linea con il modello disegnato di recente in vitro. 
L’attività generale e sostenuta del reporter nell’endotelio durante l’embriogenesi ha 
suggerito un coinvolgimento funzionale della segnalazione Yap/Taz nell’angiogenesi 
precoce. La downregolazione di Yap/Taz è risultata in una compromissione della 
crescita dei vasi intersegmentali (ISVs), mentre l’attivazione spinta della trascrizione 
mediata da Yap/Taz ha causato un ramificarsi anomalo degli ISVs. La capacità di 
Yap/Taz di promuovere tale ramificazione vascolare è “cell-autonomous”, dal momento 
che lo stesso fenomeno è stato osservato esprimendo TAZ-4SA sotto il controllo di un 
promotore endotelio-specifico. 
Lo zebrafish reporter sviluppato è un nuovo potente strumento per studiare in vivo 
l’attivazione della via di Yap/Taz, con possibili applicazioni nello screening 
farmacologico e nella biologia della rigenerazione e del cancro. Ha permesso di 
confermare in vivo durante lo sviluppo l’interazione fra le vie di Wnt/β-catenina e 
Yap/Taz e di scoprire un nuovo ruolo di Yap/Taz nella ramificazione vascolare, 
suggerendo una funzione pro-angiogenica dell’attività trascrizionale di YAP/TAZ. 
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2    INTRODUCTION 
 
2.1 Reporting in vivo a signaling pathway activity: 
transgenic zebrafish reporter lines 
 
Zebrafish (Danio rerio) is a small teleost fish that, in the last decades, thanks to its 
biological characteristics, has gained great relevance in the biomedical research as an 
outstanding model organism. Zebrafish shares all features of vertebrates, its genome has 
recently been fully sequenced and the genes identified display high sequence similarity 
with the mammalian orthologues, as well as high synteny and conservation of gene 
function (Barbazuk et al., 2000). The ease of maintenance, its small size, the short 
generation time (2-3 months) and the prolific reproduction (about 200 eggs per female 
with a weekly frequency) make zebrafish an ideal model for large-scale genetic 
screening and analysis (Driever et al., 1996; Haffter et al., 1996). Moreover, the external 
fertilization and the embryonic semitransparency are probably the biggest advantages 
that zebrafish offers to the research in developmental biology, genetics and 
physiophatology. In fact, these characteristics allow in vivo, non-invasive observation of 
early development and organogenesis and open wide possibilities for genetic 
manipulation. Messenger RNAs, antisense oligonucleotides and transgenic constructs 
can be easily microinjected in the zebrafish embryo to study gene function through 
knockdown and overexpression experiments, as well as through the generation of 
mutant, transgenic and reporter lines. Being a vertebrate, zebrafish represents a good 
model organisms to phenocopy human diseases and many fish that reproduce different 
human disorders at the molecular, cellular, histological and etiological levels have been 
generated (Lieschke and Currie, 2007; Liu and Leach, 2011; Goldsmith and Jobin, 
2012). New genetic manipulation technologies such as the CRISPR/Cas system are now 
available and, by permitting efficient and fast genome editing,  will strengthen the 
ability of the zebrafish to model human diseases and to unravel cellular, molecular and 
genetic mechanisms (Hwang et al., 2013 a; Hwang et al., 2013 b; Jao et al., 2013). 
One interesting use of zebrafish, that fully exploits its features and advantages, is 
represented by transgenic signaling pathway reporter lines, which enable the dynamic, 
in vivo monitoring of the activity of specific pathways during development and 
adulthood, in normal and pathological conditions. Embryonic and postnatal signaling 
pathways govern the basic biological processes, such as cell proliferation, survival, 
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death and differentiation, involved in animal development and tissue homeostasis and 
impaired in tumorigenesis and many other disorders. Therefore, the investigation of the 
molecular cascades of these signaling pathways, their upstream regulation, the complex 
network of interconnections and the downstream transcriptional and biological output 
takes on a crucial importance for the understanding of the biological mechanisms 
regulating physiological and pathological processes. Fundamental in regulating 
stemness, cell proliferation and differentiation are bone morphogenetic proteins 
(BMPs), Notch, wingless-related integration site (Wnt), sonic Hedgehog (Shh), 
fibroblast growth factor (FGF), signal transducer and activator of transcription (STAT), 
cAMP-response element-binding protein (CREB) and YAP/TAZ signaling (Perrimon et 
al., 2012; Aaronson and Horvath, 2002; Stork and Schmitt, 2002; Piccolo et al., 2014). 
A signaling pathway reporter zebrafish is a transgenic biosensor fish expressing a 
fluorescent protein under the control of regulatory sequences responsive to the specific 
pathway. The result is a powerful tool reporting in vivo the spatio-temporal activation of 
the signaling pathway, with many possible applications, first in development biology 
but also for studies in adult physiology, human diseases and dynamic processes such as 
regeneration and tumorigenesis. 
 
2.1.1 Generation of a signaling pathway reporter line 
 
The first condition for the development of a signaling pathway reporter line is the 
identification of the pathway-specific responsive elements (REs). Each pathway 
consists of a signaling cascade that ultimately results in the activation of certain 
transcription factors, responsible for driving the expression of the pathway target genes. 
The pathway-specific REs are those regulatory sequences located in the promoters of 
these target genes and recognised by the transcription factors activated downstream of 
the signaling cascade. The REs sequences might be already available in the literature or 
can be identified by in silico analysis of conserved promoter regions of known target 
genes. To enhance the reporter responsiveness, these REs are multimerized in a variable 
number of repeats that need to be tested experimentally, as the final effect is hard to be 
predicted (Figure 2.1). Nevertheless, it has been shown that the cooperativity among 
responsive sequences and an higher number of REs repeats enhance the reporter protein 
expression level (Moro et al., 2012; Moro et al., 2013). Of note, higher responsiveness 
doesn’t mean higher sensitivity in all experimental contexts, since the potential signal 
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saturation could be a limit in reporting activity upregulations or subtle downregulations 
(Moro et al., 2013). 
The second element a signaling pathway reporter construct needs is a minimal 
promoter to drive the expression of the reporter protein with the specificity instructed by 
the upstream multimerized REs. Minimal promoters can be taken from genes that are 
transcriptional targets of the specific pathway (Barolo, 2006; Dorsky et al., 2002; Moro 
et al., 2012); otherwise, artificial minimal promoter can be used, such as the pGL4 
vector-derived promoter miniP, which should reduce potential unspecific signals due to 
sequences other than the TATA present in the natural promoters (Shimizu et al., 2012). 
As for the number of REs repeats, the suitable minimal promoter required to be chosen 
empirically for signal-to-noise ratio, responsiveness and specificity for the given 
pathway. 
The reporter gene, placed downstream of the multimerized REs and the minimal 
promoter, is the last element to be considered for the generation of the signaling 
pathway reporter transgene. The choice of the appropriate fluorescent reporter protein 
depends on the biological processes that will be addressed, and takes into account the 
wide spectra of characteristics and properties of the different reporter proteins (Moro et 
al., 2013). Particularly important are the excitation/emission wavelengths, that influence 
the detection capacity of the specific protein fluorescence by the available optics and the 
possibility to generate double and multiple transgenics; the brightness, impacting on the 
reporter sensitivity; the half-life; the subcellular localization (e.g. cytoplasmic, nuclear, 
mitochondrial) and peculiar features of modified versions (e.g. photoconvertible and 
destabilized reporter proteins) (Shaner et al., 2005; Shaner et al., 2007; Müller-
Taubenberger and Anderson, 2007; Miyawaki, 2011). Destabilized versions of reporter 
proteins might be ideal when addressing dynamic biological processes. Good examples 
are given by the d2eGFP, a destabilized version of the enhanced green fluorescent 
protein eGFP, and the Venus-PEST, a fusion protein containing the fluorescent protein 
Venus (a derivative of enhanced yellow fluorescent protein (eYFP)) and the PEST 
sequence from the mouse ornithine decarboxylase protein that confers fast degradation 
to the fusion protein (Nagai et al., 2002; Li et al., 1998). In any case, the design of more 
reporter constructs by using different reporter genes allow to create a versatile tool for 
the investigation of both rapid and slow phenomena, possibly in other fluorescent 
protein-expressing transgenic and reporter backgrounds at the same time, and to 
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overcame issues related to a too short or too long half-life, a too weak or saturated 
signal. 
 
Figure 2.1. Generation of a zebrafish signaling pathway reporter line by the Tol2 strategy. See text 
for details (From Moro et al., 2013). 
 
The multimerized REs, the minimal promoter, the reporter gene and a polyA 
sequence are assembled together in a final destination vector exploiting the Gateway-
based Tol2 strategy, a site-specific recombination-based cloning method recently 
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emerged as a simple, quick and efficient technology for zebrafish transgenesis (Kwan et 
al., 2007). The destination vector obtained by the Gateway recombination reaction is a 
transposon-donor plasmid, whose Tol2 sequences are recognized by the transposase. 
When it is injected, together with the transposase mRNA, into one-cell stage zebrafish 
embryos, the transposase catalyzes the transgene excision and the recombination within 
the zebrafish genome. The microinjected embryos are screened for mosaic reporter 
fluorescent expression (if the reporter is expected to be active during development) and 
raised to adulthood. They are then outcrossed to wild-type fish and screened for 
germline transmission to finally establish the stable transgenic reporter line. A 
schematic representation of the whole procedure for the generation of a zebrafish 
reporter line by the Tol2 strategy is depicted in Figure 2.1. 
When using the Tol2 transgenesis system, thanks to the high integration frequency 
into the host genome during early developmental stages, the rate of germline 
transmission to the offspring reaches around 70% of the microinjected fish. The high 
transgenesis rate can raise the question of multiple integration events occurring in the 
germline and consequently the presence of multiple copies of the transgene in single 
individuals of the offspring (Moro et al., 2013). Possible complications are the non-
Mendelian inheritance of the transgene and the variability within the offspring from the 
same founder, both in terms of reporter expression level and in terms of reporter 
expression pattern, caused by the presence of a variable number of copies of the 
transgene and the influence that a different genomic environment could have on the 
transgene expression (“positional effect”). 
 
2.1.2 Validation of a signaling pathway reporter line 
 
Before to use a zebrafish reporter line for any biomedical application, it is essential 
to ensure that the transgenic line is effectively reporting the activity of the desired 
pathway, i.e. is a bona fide reporter for a specific signaling pathway. The validation of a 
reporter line is the body of experimental observations and tests showing that the signal 
detected is a reliable readout of the signaling pathway activity. The major approaches 
adopted to validate a signaling pathway reporter line are represented by the comparison 
of multiple reporter lines, literature review, genetic and pharmacological perturbation of  
the pathway (Moro et al., 2013). 
A first indication of the consistency of the reporter is given by the comparison of the 
spatio-temporal expression pattern of the reporter protein in the progenies from several 
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founder fish. The positional effect and the presence of multiple transgenic alleles in the 
same carrier, as mentioned before, can explain possible discrepancies in the reporter 
protein expression pattern and intensity. This issue can usually be attenuated by diluting 
the number of transgenic copies through subsequent generations and by selecting 
individuals with most shared signals (Moro et al., 2013). A stronger validation step in 
comparing multiple reporter lines is given by the sharing of a similar reporter 
expression pattern with transgenic lines reporting the same pathway but based on 
different designs of the REs and/or the minimal promoter components. These reporter 
lines might be already available in the literature (a clear example is given by the case of 
the Wnt reporter lines in Dorsky et al. (2002), Moro et al. (2012) and Shimizu et al. 
(2012)). 
Literature review in the validation process consists in the comparison of the 
information acquired from the reporter line, about the anatomical districts and the time 
points in which the reporter is activated, with the data available in the current literature. 
These might be known profiles of target genes of the given signaling pathway and data 
relative to the activity and the function of that signaling during development, in adult 
tissues and organs or in particular biological processes (Moro et al., 2013). 
The fundamental step required for the validation of a signaling pathway reporter line 
is the one that shows if the transgenic line is able to report variations in the activity of 
the pathway under investigation. Perturbations of the signaling can be achieved 
genetically or pharmacologically; with both approaches the aim is to monitor if the 
reporter protein expression level varies as expected from the known perturbation 
experimentally induced. Genetic methods to up- and downregulate the pathway activity 
include overexpression of mRNAs encoding for “natural” or dominant-active/negative 
versions of pathway components and knockdown by antisense morpholino oligos 
injection. Transient activity of mRNAs and morpholinos can be overcome by using 
stable transgenic lines or genetic mutants. To have a reporter line in a mutant 
background, reporter fish are first outcrossed to the genetic mutant and the heterozygous 
mutants obtained are then intercrossed. Heat shock inducible line may be available too 
and are particularly useful, as they permit to analyze the effect of the overexpression of 
pathway members skipping the possible early embryonic lethality of mutants and non-
conditional systems. On the other hand, pharmacological methods entail the use of 
drugs represented by known chemical agonists or antagonists, possibly acting at 
different levels of the signaling cascade (Moro et al., 2013). 
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So far, the best way commonly recognised to conclude that a zebrafish transgenic 
line is a bona fide reporter for a specific signaling pathway remains the combined use of 
all the strategies described above (Moro et al., 2013). 
 
2.1.3 Applications and limits of signaling pathway reporter lines 
 
The first application of any zebrafish reporter line concerns the visualization and the 
analysis of the physiological activation of the pathway throughout vertebrate 
development and in adult tissues and organs (Dorsky et al., 2002; Molina et al., 2007; 
Schwend et al., 2010; Gorelick and Halpern, 2011; Moro et al., 2012). Thanks to the 
semitransparency of zebrafish during embryonic and early larval development, and the 
availability of unpigmented fish lines, reporter activation can be followed in vivo at 
single-cell resolution during gastrulation, segmentation and organogenesis, until 
juvenile stages. The signaling pathway activation can be dissected also in adulthood, but 
the in vivo analysis becomes limited to superficial structures, including interesting 
applications in regenerative biology. Good examples are given by the Yap/Taz reporter 
activity visualized in vivo in the endothelial wall of the adult fin vessels, reported in this 
thesis, and the activation of reporter signals during the epimorphic fin regeneration after 
amputation (this thesis and Moro et al., 2012). Reporter expression in internal tissues 
and organs is visualized by post-mortem dissection and subsequent direct fluorescence 
microscopy and/or immunostaining (Moro et al., 2013). 
The possibility to treat living reporter fish with several chemical compounds and to 
monitor signal variations, potentially with automated systems, opens wide perspectives 
to the use of zebrafish reporter lines in the screening and validation of novel, 
therapeutically relevant drugs acting as agonists or antagonists of the considered 
signaling pathway (Weger et al., 2012; Moro et al., 2013). 
The increasing number of zebrafish reporter lines available, together with the option 
of many different reporter proteins, makes wider and wider the variety of cross 
relationships among genes and signaling pathways that can be studied in vivo in 
zebrafish. The applications of double/multiple transgenics ranges from simple co-
localization analysis to crosstalk/epistasis studies in physiological or pathological 
contexts (Moro et al., 2013). 
One of the most important applications of the zebrafish reporter lines in the future 
will be their usage to explore signaling pathways activation and role in human diseases, 
taking advantage of  the several zebrafish models of human disorders already developed 
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and that will be developed in the near future. The activity of a given signaling pathway 
can be followed during different stages or conditions of the disease progression, such as 
pre-cancerous lesions, carcinoma in situ and metastasis for an epithelial tumor (Moro et 
al., 2013; Schiavone et al., 2014). 
Despite the plethora of opportunities offered by the zebrafish signaling pathway 
reporter lines, some limitations have also to be considered. A given reporter line, in fact, 
may not be able to fully recapitulate the activity of the signaling pathway. Anatomical 
districts effectively activating the pathway may not show the corresponding activation 
of the reporter, possibly due to the threshold level required to visualize the reporter 
protein, issue that could be partially overcame by in situ hybridization detection of the 
reporter transcript (Molina et al., 2007; Moro et al., 2013). Local chromatin effects at 
the level of the transgene insertion may also be responsible for an incomplete signaling 
recapitulation (Schwend et al., 2010). Another limit could be represented by the 
persistent expression of stable fluorescent reporter proteins (especially in those tissues 
with a limited protein turnover) also when the signaling activity has already been turned 
off (Moro et al., 2013). One limitation by which all zebrafish reporter lines are affected 
is given by the fact that REs recognised by specific transcription factors are used in the 
transgenic construct. This means that, if the signaling pathway under investigation 
somehow activates different transcription factors, for example less known or less 
represented, the reporter is not able to report this activity. On the contrary, if the 
transcription factors recognising the REs are activated also by pathways different from 
the one considered, the case can not be distinguished, as the reporter protein is anyhow 
expressed. 
 
 
2.2 YAP/TAZ signaling 
 
YAP and TAZ have been considered for years as simple downstream effectors of the 
Hippo pathway, a tumor suppressor pathway first discovered in Drosophila and defined 
as “Salvador-Warts-Hippo” pathway only twelve years ago (Wu et al., 2003). The most 
fascinating biological property of the Hippo pathway regards the still mysterious 
capacity to stop the growth of organs when they reach their correct size, basically by 
turning off Yorkie, the YAP/TAZ orthologue in Drosophila. From there, the field has 
incredibly evolved and YAP/TAZ are more and more appearing as key players among a 
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complex network of signalings during development, by orchestrating cell proliferation, 
cell death and cell-fate decisions. Deregulation of YAP/TAZ signaling is responsible for 
robust organ overgrowth during organogenesis (as first shown in Drosophila by Hippo 
mutants), which translates to loss of tissue homeostasis control in the adult and 
consequent cancer development. Thus, aberrant YAP/TAZ signaling is emerging as 
central determinant of malignancy in human cancer, as well as controlled YAP/TAZ 
signaling is essential for normal development, tissue homeostasis and regeneration 
(Piccolo et al., 2014). 
YAP/TAZ are transcriptional co-activators and drive the transcription of a set of 
target genes by binding TEAD transcription factors. Important target genes are: CTGF, 
CYR61, ANKRD1, BIRC5, AXL, InhA, Col8a1. To be considered, TEAD transcription 
factors interact also with transcriptional co-activators other than YAP/TAZ, such as 
those belonging to the Vestigial family, as well as YAP/TAZ bind other nuclear 
proteins and transcription factors, such as RUNX, p73 and PPAR-γ (Piccolo et al., 
2014). 
YAP/TAZ field is still very young and many aspects of YAP/TAZ biology remain to 
be explored, starting from the poorly understood upstream regulators and downstream 
effectors of the pathway. Moreover, recent discoveries showing a variety of YAP/TAZ 
regulators independent of Hippo, such as biomechanical stimuli and a strict crosstalk 
with other pathways (the Wnt/β-catenin above all; see below), are opening the road to 
intriguing questions and possibly to new exciting horizons in YAP/TAZ biology 
(Piccolo et al., 2014). 
Because of the large complexity of YAP/TAZ signaling, the following presentation 
of the pathway regulations and functions will take into consideration the most important 
known aspects of the field, far to claim to be comprehensive. 
 
2.2.1 YAP/TAZ as nuclear transducers of the Hippo pathway  
 
The Hippo pathway is an evolutionary-conserved tumor suppressor pathway, whose 
core is composed of a kinase cascade ultimately resulting in YAP/TAZ/Yorkie 
phosphorylation and inhibition. In mammals, the sterile 20-like kinases MST1/STK4 
and MST2/STK3 (orthologues of the Drosophila Hippo kinase), when bound to their 
regulatory protein SAV1/WW45 and activated by upstream signals, phosphorylate and 
activate the LATS1/2 kinases (orthologues of Warts), together with their regulatory 
subunits MOB1A/B (Chan et al., 2005; Praskova et al., 2008). In turn, 
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LATS1/2/MOB1A/B complex phosphorylates YAP and TAZ (Dong et al., 2007; Zhao 
et al., 2007; Lei et al., 2008). LATS1/2 phosphorylate YAP at five and TAZ at four 
serine/threonine residues (Zhao et al., 2010). In particular, phosphorylation of S381 in 
YAP and S311 in TAZ is responsible for their polyubiquitylation and degradation. In 
fact, it is followed by additional phosphorylation by CK1 kinases, which generates a 
“phosphodegron” recognized by β-transducin repeat-containing protein β-TrCP, a key 
adaptor for the SCF E3 ubiquitin ligases (Liu et al., 2010; Zhao et al., 2010; Zhao et al., 
2010). On the other hand, phosphorylation of S127 in YAP and S89 in TAZ creates a 
binding consensus for 14-3-3 proteins, responsible for YAP/TAZ sequestration in the 
cytoplasm (Dong et al., 2007; Zhao et al., 2007; Basu et al., 2003). YAP is mainly 
regulated through this mechanism, as it is a relatively stable protein, while TAZ is very 
unstable, with a half-life shorter than two hours, indicating that its major regulation is 
represented by protein degradation via polyubiquitylation (Piccolo et al., 2014). LATS-
induced phosphorylation is reverted by phosphatases such as PP1 (Liu et al., 2011; 
Wang et al., 2011). Other post-translational modifications and protein interactions may 
also influence YAP/TAZ activity. Considering the different mechanisms of YAP/TAZ 
inhibition, including nuclear exclusion, sequestration in the cytoplasm and proteasomal 
degradation, YAP/TAZ transcriptional activity is overall regulated by their 
nucleocytoplasmic shuttling and nuclear accumulation. Essentially, focusing on the 
Hippo-dependent regulation, when the Hippo pathway is active, YAP/TAZ are 
transcriptionally inactive. Only when the Hippo cascade releases its inhibition, 
YAP/TAZ are translocated in the nucleus, where they drive the transcription of their 
target genes (Piccolo et al., 2014) (Figure 2.2). 
Proteins involved in cell-cell adhesion and apical-basal polarity complexes are the 
main upstream regulators of the Hippo pathway. Merlin/NF2 is localized in close 
proximity to adherens and tight junctions and inhibits YAP/TAZ by activating the 
Hippo cascade through different possible mechanisms and protein interactions, not 
completely understood (Piccolo et al., 2014). Merlin is a member of the 
Expanded/Merlin/Kibra complex, which may function as an apical scaffold by 
recruiting the core Hippo pathway proteins at cell-cell junctions and promoting LATS 
activation (Genevet et al., 2010; Yu et al., 2010; Baumgartner et al., 2010; Xiao et al., 
2011; Yin et al., 2013; Moleirinho et al., 2013) (Figure 2.2). 
Scribble is a key cell polarity determinant localized at the plasma membrane, where 
serves as adaptor for the assembly of a complex containing MST, LATS and TAZ and 
21 
 
promoting MST-mediated activation of LATS. Loss of the epithelial architecture, such 
as during epithelial-to-mesenchymal transition in cancer, triggers Scribble 
delocalization and consequent TAZ and likely YAP activation, which is responsible for 
the acquisition of cancer stem cell like traits and the malignant properties of the tumor 
(Cordenonsi et al., 2011) (Figure 2.2). Similarly to Scribble, the Crumbs apical complex 
binds to YAP/TAZ and promotes their phosphorylation and cytoplasmic retention, 
through a not well known mechanism (Varelas et al., 2010). 
 
Figure 2.2. Schematic representation of the Hippo pathway-mediated regulation of YAP/TAZ. 
YAP/TAZ nucleocytoplasmic shuttling is depicted as the balance among nuclear translocation/exclusion, 
proteasomal degradation and cytoplasmic sequestration. The Hippo pathway upstream regulators Scribble 
and NF2 are also shown (From Piccolo et al., 2014).  
 
E-cadherin/α-catenin complex, involved in cell adhesion and linked to the actin 
cytoskeleton, also inhibits YAP activity in normal conditions, probably by activating 
LATS or a yet unknown kinase phosphorylating YAP in the same residues targeted by 
LATS (Kim et al., 2011; Schlegelmilch et al., 2011). Again, perturbations of the cell 
adhesion, in this case disturbing the E-cadherin/α-catenin complex, impairs YAP 
inhibition and promotes its nuclear accumulation (Varelas et al., 2010). E-cadherin/α-
catenin-mediated regulation of YAP/TAZ activity takes also part in the process by 
which cultured cells stop dividing when they become confluent, the historical 
knowledge of epithelial biology termed contact inhibition of proliferation (CIP). When 
cultured cells start making contacts with each other, the E-cadherin/α-catenin system 
activates LATS, leading to YAP/TAZ phosphorylation and proliferation arrest. 
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However, this mechanism accounts for only ~30% of YAP/TAZ-mediated CIP, that is 
mainly regulated by the YAP/TAZ mechanical pathway (see below) (Aragona et al., 
2013). 
 
2.2.2 YAP/TAZ as sensors and mediators of mechanical cues  
 
Independently of the Hippo pathway, YAP/TAZ are strongly susceptible to signals 
coming from the physical properties of the microenvironment experienced by the cell. 
These include mechanical stimuli derived from the elasticity of the extracellular matrix 
(ECM), the forces exerted by neighbouring cells and the pressure experimented by the 
tissue at a more general level. YAP/TAZ are able to sense mechanical cues and to 
transduce them into a biological response of death/proliferation or differentiation 
decisions guided by YAP/TAZ-mediated target genes transcription. Specifically, the 
stretching of a single cell over the ECM and the consequent adaptation of the 
cytoskeleton cause YAP/TAZ nuclear accumulation, promoting cell proliferation and 
inhibiting differentiation. On the contrary, if cell adhesion is restricted to a very small 
ECM area and the cell acquires a round, compact shape, YAP/TAZ are inactivated and 
the biological response is reverted. YAP/TAZ are active mediators of the cell decisions 
induced by cell morphology change: YAP/TAZ artificial inactivation in stretched cells 
causes the cells to behave as if they were on small adhesive areas, while YAP/TAZ 
artificial activation in round cells cause the cells to behave as if they were stretched. 
Similarly, YAP/TAZ sense and transduce signals concerning ECM stiffness: a rigid 
ECM promotes their activity in the nucleus, whereas a soft ECM excludes them from 
the nucleus (Dupont et al., 2011) (Figure 2.3). 
YAP/TAZ regulation by mechanical cues requires Rho GTPase activity and the 
tension of the actomyosin cytoskeleton. In fact, the remodeling of the F-actin 
cytoskeleton regulated by the Rho family of GTPases was shown to control YAP/TAZ 
activity. F-actin regulation is mediated by the F-actin capping and severing proteins 
Cofilin, CapZ and Gelsolin, but the mechanism linking the F-actin cytoskeleton with 
YAP/TAZ activity remains to be uncovered, ascertained the fact that is independent of 
LATS and of any phosphorylation of YAP/TAZ. This cytoskeletal/mechanical pathway 
explains the complete proliferation arrest occurring in CIP process after LATS 
activation by the E-cadherin/α-catenin system (see above). Independently of LATS, the 
remodeling of the F-actin cytoskeleton represents the second step in CIP. The 
mechanism is the same described for single cells plated on small ECM islands: after 
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reaching confluence, cell crowding in the monolayer restricts cells into smaller areas, 
causing the F-actin cytoskeleton remodelling responsible for YAP/TAZ nuclear 
exclusion and proliferation inhibition (Halder et al., 2012; Aragona et al., 2013). 
 
Figure 2.3. YAP/TAZ as sensors and mediators of mechanical cues. The area of ECM available for 
cell adhesion and the ECM stiffness regulate YAP/TAZ activity, leading to different biological response 
of death/proliferation and differentiation (From Piccolo et al., 2014). 
 
2.2.3 YAP/TAZ in embryonic development 
 
Yap/Taz double knockout embryos die at morula stages, Yap knockouts die shortly 
after gastrulation, while Taz knockouts, even if with an high rate of embryonic lethality, 
can complete development but die of polycystic kidney disease and pulmonary 
emphysema (Nishioka et al., 2009; Morin-Kensicki et al., 2006; Hossain et al., 2007; 
Makita et al., 2008). In the blastocyst an interesting patterning in YAP/TAZ subcellular 
localization is observed. The cells of the inner cell mass (ICM), nonpolar and 
expressing pluripotency transcription factors such as Oct4 and Sox2, display YAP/TAZ 
enrichment in the cytoplasm, while in the outer cells of the trophoblast, with a strong 
apicobasal polarity and expressing Cdx2 mastergene, YAP/TAZ are localized in the 
nucleus. Forced activation of YAP and TEAD is sufficient to induce Cdx2 expression in 
the ICM; conversely, LATS overexpression suppresses Cdx2 expression in the 
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trophoblast (Nishioka et al., 2009). Overall, these data indicate a crucial role of 
YAP/TAZ signaling in the first cell fate decision occurring during early embryonic 
development. 
As mentioned before, the Hippo pathway is a key regulator of organ growth and 
organ size during development. Defects in components of the Hippo cascade, causing 
the loss of YAP/TAZ inhibition, as well as YAP/TAZ overexpression have been shown 
to determine a robust overgrowth phenotype in many organs and model organisms such 
as Drosophila, mice and zebrafish. As an example, YAP overexpression in developing 
mouse hearts increases the organ size in a TEAD-dependent manner, and the same 
phenotype was obtained after Mst1/2 and Lats2 inactivation (Heallen et al., 2011; Song 
et al., 2010). On the contrary, mice undergoing conditional deletion of Yap in 
embryonic cardiomyocytes display severe heart hypoplasia due to proliferation 
impairment, similar to what observed in Tead1 knockouts (Chen et al., 1994; Sawada et 
al., 2008; von Gise et al., 2012; Xin et al., 2013). 
A surprising phenotype appears when YAP and TAZ are inactivated in the 
developing kidney, representing also an example of possible distinct functions that YAP 
and TAZ may have in some districts or conditions. In fact, Yap conditional knockout 
within the nephrogenic lineage shows that YAP is essential for nephron induction and 
morphogenesis, in a manner independent of regulation of cell proliferation and 
apoptosis. On the other hand, Taz knockout causes polycystic kidney disease (Reginensi 
et al., 2013; Hossain et al., 2007; Makita et al., 2008). 
 
2.2.4 Role of YAP/TAZ in the adult tissues and in regeneration 
 
In the adult tissues such as brain, intestine, skin, and skeletal muscle YAP and/or 
TEAD expression was found to be enriched in anatomical compartments containing 
stem/progenitor cells (Ramos and Camargo, 2012). Consistently with the role of 
YAP/TAZ in prompting tissue proliferation during development until organs reach their 
proper size, a forced activation of YAP/TAZ signaling in adult organs leads in general 
to expansion of progenitor cells, aberrant proliferation and organ enlargement. 
Paradigmatic is the fourfold increase in liver mass in transgenic mice overexpressing 
YAP and the similar overgrowth phenotype observed in liver-specific Mst1/2 knockout 
mice (Camargo et al., 2007; Dong et al., 2007; Lu et al., 2010). In the intestine, 
expression of endogenous YAP is restricted to the progenitor/stem cell compartment, 
and YAP overexpression expands the undifferentiated progenitor cells, without 
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affecting whole organ size (Camargo et al., 2007). Similarly, YAP overexpression in the 
basal layer of the epidermis increases keratinocytes proliferation, leading to defective 
stratification and reduced differentiation (Zhang et al., 2011). Apparently in contrast 
with these observations, Mst1/2 conditional knockout in murine pancreas induces a 
reduction of organ size. Nevertheless, the increased YAP activity in the pancreas 
maintains ductal cells in an active proliferation status, but their overgrowth is likely 
balanced by tissue autodigestion due to defective formation of the pancreatic ducts 
(George et al., 2012; Gao et al., 2013). 
Despite the tremendous impact that loss of YAP/TAZ signaling has on early 
development, YAP/TAZ inactivation in adult tissues may be inconsequential. The best 
example is given by the double conditional knockout in the intestinal epithelium, 
showing how YAP/TAZ are dispensable for normal tissue homeostasis (Azzolin et al., 
2014). Liver homeostasis, instead, is disrupted by YAP/TAZ signaling inactivation. In 
particular, Yap conditional knockout in mouse liver leads to loss of hepatocytes and 
biliary epithelial cells due to decreased proliferation and increased apoptosis (Zhang et 
al., 2010). In the heart, Yap deletion after cardiomyocytes maturation results in dilated 
cardiomyopathy with thinning of the ventricular walls and possibly heart failure; the 
disease is accelerated by Yap/Taz double knockout, while Taz inactivation alone has no 
effect (Xin et al., 2013). 
In the adult tissues, YAP/TAZ signaling plays a fundamental role in regeneration. 
YAP and possibly TAZ have been show to promote both the reprogramming of 
differentiated cells and the expansion of stem and progenitor cell populations, two key 
processes intervening during regeneration after different types of tissue injury. A 
number of studies highlighted how YAP/TAZ activation appears as a necessary and 
evolutionary-conserved step during regeneration of different organs (Johnson and 
Halder, 2014). In a mouse model of cholestatic injury, Yap liver knockout compromises 
bile duct and hepatocyte proliferation, but also enhances hepatocyte necrosis (Bai et al., 
2012). After myocardial infarction, cardiac-specific deletion of Yap decreases 
cardiomyocyte proliferation and increases apoptosis and fibrosis. Conversely, YAP 
overactivation stimulates cardiac regeneration, which resulted to be correlated with 
YAP activation of embryonic and proliferative gene programs in cardiomyocytes (Xin 
et al., 2013; Del Re et al., 2013). Particularly interesting is the case of intestine 
regeneration, since lack of YAP/TAZ in this tissue has no consequences in normal 
conditions (see above). However, during intestinal regeneration, increased YAP 
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expression is registered and lack of YAP impairs the regenerative response (Cai et al., 
2010), thus showing the potentiality of YAP/TAZ signaling reactivation for the 
regulation of tissue proliferative homeostasis. 
 
2.2.5 Role of YAP/TAZ in cancer 
 
YAP/TAZ signaling might be seen as a finely tunable system that tissues and organs 
use to keep under control the balance between cell proliferation and cell death, tissue 
growth and growth arrest. During development this balance is more shifted toward 
proliferation and growth, until the signaling is progressively silenced and restricted to 
the small stem/progenitor cells niches. Conditions such as different types of injury 
require the reactivation of YAP/TAZ signaling in order to trigger transient expansion of 
progenitors for the replacement of the damaged tissue. However, similarly to what 
happens when YAP/TAZ signaling remains overactive during development, leading to 
the growth of the organs beyond their physiological limit, an aberrant activation of the 
pathway in the adult tissues means the proliferative homeostasis out of control and thus 
cancer. 
This vision is strongly supported by numerous studies showing how YAP and TAZ 
are activated with a very high frequency in a variety of human malignant tumors, such 
as ovarian, colon, gastric, liver, esophageal, lung, breast cancers. Moreover, YAP/TAZ 
aberrant activation is associated with metastasis and poor outcome. Functionally, 
YAP/TAZ signaling is able to sustain tumor progression toward malignancy in different 
ways, by exploiting the same biological properties that promote and regulate normal 
organ growth. These are represented by proliferation, cell survival and “stemness” 
(Piccolo et al., 2014). Cell survival is promoted for example by the YAP-mediated 
blocking of TNF-α and FAS-induced cell death, while TAZ is able to foster the 
resistance to the chemotherapeutic drug Taxol in human breast cancer (Dong et al., 
2007; Lai et al., 2011). Stem cell properties of the so-called cancer stem cells (e.g. 
proliferative potential, self-renewal, chemotherapy resistance) are promoted in breast 
cancer by TAZ activity, which is required and sufficient to sustain these cancer stem 
cell features (Cordenonsi et al., 2011). 
What really turns on YAP/TAZ signaling in cancer is poorly understood, since 
mutations in Hippo pathway components may account for an extremely scant number of 
cases. Altered tissue architecture and mechanical cues derived from changes in ECM 
rigidity may explain at least part of the general YAP/TAZ activation. Intense research is 
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still needed to unravel more complete mechanisms driving YAP/TAZ behaviour and 
their biological responses in cancer, and to design novel therapeutic strategies aimed at 
disrupting the malignant YAP/TAZ potential (Piccolo et al., 2014). 
 
 
2.3 Crosstalk between YAP/TAZ and Wnt/β-catenin 
pathway 
 
YAP/TAZ signaling has been shown to interact with a number of other signaling 
pathways, such as Wnt/β-catenin, TGF-β/BMP, Notch, Hedgehog, HIF/hypoxia, cAMP 
and Rho GTPases signalings, during development, regeneration and cancer. The most 
known and likely the strictest crosstalk is that between YAP/TAZ and Wnt/β-catenin 
pathways. Indeed, recent discoveries indicate how, more than distinct pathways 
speaking to each other, they are better described as a unique signaling network, 
regulated by a complex body of upstream players and regulating a wide panorama of 
instrumental biological responses. 
 
2.3.1 The Wnt/β-catenin pathway 
 
The Wnt/β-catenin pathway shares key biological functions with YAP/TAZ, since 
Wnt ligands activating the pathway belong to a family of growth factors involved in cell 
proliferation, stem cell expansion, regeneration and tumorigenesis. The Wnt/β-catenin 
or canonical pathway is one of the three different pathways activated upon Wnt receptor 
activation, together with the noncanonical planar cell polarity pathway and the 
Wnt/Ca
2+
 pathway (Clevers, 2006). 
Canonical Wnt signaling relies on the regulation of the transcriptional co-activator β-
catenin by a cytoplasmic destruction complex. Basically, in the absence of Wnt signal, 
the destruction complex keeps the levels of free β-catenin in the cytoplasm low by 
driving it to degradation. The arrival of a Wnt ligand stabilizes β-catenin, which then 
translocates into the nucleus leading to the pathway target genes transcription. β-catenin 
destruction complex is composed of the central scaffold protein AXIN, the 
adenomatous polyposis coli (APC) and the two kinases casein kinase 1 (CK1) and 
glycogen synthase kinase-3 (GSK3). AXIN and APC act as scaffolds for the kinases 
activity on β-catenin. When Wnt signaling is off, CK1 and GSK3 sequentially 
phosphorylate β-catenin on conserved Ser/Thr residues. Phosphorylated β-catenin is 
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recognised and ubiquitylated by β-TrCP, a component of a dedicated E3 ubiquitin ligase 
complex, that targets β-catenin to proteasomal degradation. Wnt signaling is initiated by 
the Wnt ligands, a family represented in mammals by roughly 20 cysteine-rich secreted 
glycoproteins acting as morphogens. Wnts bind to Frizzled (Fz) proteins, which are 
transmembrane receptors with an extracellular N-terminal cysteine-rich domain, and to 
low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6). Direct binding to 
LRP5/6 is used also by the secreted Dikkopf (Dkk) proteins, to conversely antagonize 
Wnt signaling. The formation of Wnt/Fz/LRP5/6 complex enables Fz-mediated 
interaction with the cytoplasmic protein Dishevelled (Dvl). Dvl and LRP5/6 
cytoplasmic tail are phosphorylated by CK1 and GSK3, leading to the recruitment of 
AXIN from the destruction complex to the plasma membrane, where it directly binds 
LRP5/6. This is the key event causing the functional inactivation of the destruction 
complex, β-catenin accumulation and its nuclear translocation (Clevers, 2006; 
Konsavage and Yochum, 2013) (Figure 2.4). 
 
Figure 2.4. Schematic representation of the canonical Wnt/β-catenin pathway. See text for details 
(From Clevers, 2006. Reprinted with permission). 
 
Within the nucleus, β-catenin binds TCF/Lef transcription factors. In the absence of 
Wnt signals, TCF acts as a transcriptional repressor bound to Groucho/TLE complex. 
However, β-catenin arrival displaces Groucho/TLE co-repressor, converting TCF/Lef 
into an activator. Other transcriptional co-activators are also recruited, including the 
histone acetylase CBP/p300 and the component of the SWI/SNF chromatin remodeling 
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complex BRG1. Altogether, they affect local chromatin status permitting the 
transcription of Wnt/β-catenin target genes. Numerous TCF/Lef target genes, such as 
Axin, cMyc, CyclinD1, have been identified, promoting cell proliferation but also 
controlling fate determination and terminal differentiation. The different transcriptional 
outputs is mainly ascribed to the developmental identity of the responding cell, resulting 
cell type-specific (Clevers, 2006; Konsavage and Yochum, 2013) (Figure 2.4). 
 
2.3.2 Wnt signaling regulates YAP/TAZ activity 
 
A recent discovery indissolubly linked YAP/TAZ activity to the Wnt signaling, as it 
demonstrated that YAP and TAZ are integral component of the β-catenin destruction 
complex. From here important functional consequences derive, impacting on both 
Wnt/β-catenin and YAP/TAZ biology. The destruction complex not only sequesters β-
catenin, impeding its nuclear activity, but it also serves as cytoplasmic sink for 
YAP/TAZ, regulating their stability and nuclear availability. YAP/TAZ association to 
the destruction complex is mediated by AXIN. The binding requires the same domain of 
AXIN recognised by LRP5/6. Thus, Wnt signaling, by promoting LRP5/6-mediated 
AXIN recruitment at the plasma membrane, physically dislodges YAP/TAZ from the 
destruction complex. As a consequence, YAP/TAZ are free to enter the nucleus and 
activate transcription. These findings depict a scenario in which Wnt signaling emerges 
as a potent regulator of YAP/TAZ nuclear activity, in the same way as it regulates the 
nuclear activity of β-catenin. In the absence of a Wnt signal, both β-catenin and 
YAP/TAZ are sequestered in the cytoplasm and inactivated, while a Wnt signal causes 
the concomitant nuclear translocation and activation of β-catenin and YAP/TAZ 
(Azzolin et al., 2014). For TAZ, but not for YAP, besides the cytoplasmic sequestration 
the destruction complex represents also a means of degradation. In fact, within the 
complex, phosphorylated β-catenin bridges TAZ to its ubiquitin ligase β-TrCP, by a 
phosphorylated β-catenin/TAZ/β-TrCP association that leads to TAZ degradation 
(Azzolin et al., 2012) (Figure 2.5). 
In such a context, YAP/TAZ appear as mediators of Wnt signaling and as a branch of 
the Wnt transcriptional effects. Therefore, YAP/TAZ enters the world of Wnt biological 
outcomes, so that a significant fraction of Wnt target genes and Wnt-induced biological 
responses are actually YAP/TAZ-dependent. Aberrant intestinal crypts proliferation 
upon loss of the APC tumor suppressor is a perfect example of this. APC inactivation in 
conditional knockout mice is indeed a model to study the effects of Wnt signaling on 
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the expansion of progenitor cells. YAP/TAZ were revealed to be essential for the APC 
loss-induced crypts expansion, since APC/YAP/TAZ triple knockout mice display a 
complete rescue of the intestinal phenotype, overcoming the rapid death provoked by 
the sole APC deficiency (Azzolin et al., 2012; Azzolin et al., 2014). 
 
Figure 2.5. Crosstalk between YAP/TAZ and Wnt/β-catenin pathway. On the left, in the absence of 
Wnt signals, the β-catenin destruction complex sequesters and inactivates YAP/TAZ together with β-
catenin. On the right, upon Wnt signaling, YAP/TAZ are dislodged from the destruction complex, leading 
to the concomitant nuclear translocation and activation of β-catenin and YAP/TAZ. See text for details 
(From Piccolo et al., 2014). 
 
2.3.3 YAP/TAZ as antagonists of Wnt/β-catenin signaling in the cytoplasm 
 
YAP/TAZ incorporation in β-catenin destruction complex has also a significance 
different from the regulation exerted by Wnt signals on YAP/TAZ activity, that explains 
the function of YAP/TAZ cytoplasmic proteins as antagonists of Wnt/β-catenin 
signaling. YAP/TAZ associated to AXIN within the destruction complex, in fact, are 
essential for β-TrCP recruitment to the complex. In the absence of Wnt signals, this 
means that YAP/TAZ are required for β-catenin degradation, and depletion of 
YAP/TAZ leads to the activation of β-catenin, without the need of a Wnt upstream 
signal (Azzolin et al., 2014) (Figure 2.5). 
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The biological meaning of this YAP/TAZ cytoplasmic role is apparent in mouse ES 
cells, where YAP/TAZ depletion can substitute GSK3 inhibition in maintaining ES cells 
in undifferentiated/self-renewing state. YAP/TAZ depletion has no effect for ES cells 
maintenance in the classic medium supplied with the GSK3 inhibitor, so YAP/TAZ 
nuclear activity is irrelevant in these conditions. But, in the absence of the GSK3 
inhibitor, cytoplasmic YAP/TAZ depletion is able to block β-TrCP-mediated 
degradation of β-catenin, thus restoring the β-catenin-dependent transcriptional response 
necessary for ES self-renewal (Azzolin et al., 2014). 
Another way by which cytoplasmic YAP/TAZ antagonizes Wnt signaling is offered 
by TAZ, that was shown to inhibit the CK1-mediated phosphorylation of Dvl. This 
blocks Wnt signal transduction from the plasma membrane to the destruction complex, 
impeding β-catenin release and nuclear activity (Varelas et al., 2010). 
 
 
2.4 Hippo pathway and YAP/TAZ: is angiogenesis on the 
way too? 
 
The angiogenesis is the process of new vessels formation upon sprouting of 
capillaries from pre-existing vessels. The results shown in this thesis suggest a role of 
YAP/TAZ-mediated transcription in vertebrate angiogenesis, come from observations 
of developmental angiogenesis in a YAP/TAZ zebrafish reporter line. No direct link 
between YAP/TAZ-mediated transcription and angiogenesis exists in the literature. 
However, very recent publications are unraveling novel interactions between signaling 
and metabolic pathways promoting angiogenesis and YAP/TAZ signaling. These 
findings open at least the intriguing possibility of a YAP/TAZ involvement in this 
process as mediators of these pathways in angiogenesis regulation. 
Before to present these advances, a brief introduction follows, about the use of 
zebrafish as a powerful tool and model to study developmental, physiological and 
pathological angiogenesis. 
 
2.4.1 Studying angiogenesis in the zebrafish model 
 
The zebrafish vasculature and the basic vascular plan of the developing embryo are 
remarkably similar to those in the other vertebrates and in mammals (Roman and 
32 
 
Weinstein, 2000; Isogai et al., 2001; Lawson and Weinstein, 2002). Developmental 
vasculogenesis, angiogenesis and vascular remodelling involve the same vascular 
growth and differentiation factors involved in mammals (Lawson and Weinstein, 2002), 
and the physiophatology of the vascular system is also highly similar between zebrafish 
and mammals (Lambrechts and Carmeliet, 2004; Dejana et al., 2009). 
In zebrafish development, primary vessels form in a process known as 
vasculogenesis: at 13 somite-stage, endothelial cells precursors migrate from the lateral 
mesoderm and originate the first single circulatory loop present at 24 hours post 
fertilization (hpf). Subsequent vasculature development occurs by angiogenic processes, 
in particular in the formation of the intersegmental vessels (ISVs) of the trunk, which 
start sprouting from the dorsal aorta at 20 hpf (Isogai et al., 2001). This primitive 
embryonic vasculature expands by angiogenesis during later development and will be 
remodelled into the mature vascular system of the adult fish. Zebrafish cardiovascular 
system develops considerably fast, since a beating heart, a complete circulation loop 
and circulating erythroblasts are found as soon as at 24 hpf (Jensen et al., 2011). 
These features, coupled with the general advantages of the zebrafish model organism 
described before, such as the extra uterine development, the transparency and the 
genetic amenability, make zebrafish a powerful experimental platform to study 
physiological and pathological angiogenesis (Jensen et al., 2011; Santoro, 2014). 
Moreover, transgenic zebrafish are available, expressing fluorescent proteins in 
particular districts of the cardiovascular system, that enable in vivo monitoring of 
angiogenic processes at single-cell resolution in such a quick and versatile way 
impossible to realize in mammals (Herbert et al., 2009; Jensen et al., 2011). Commonly 
used transgenic lines are those based on the fli1a or kdrl promoters, labeling the whole 
vasculature, and on the gata1 promoter, driving the transgene expression in the 
erythrocytes (Jensen et al., 2011). 
Pharmacological screens and analysis of chemicals interfering with or promoting 
angiogenesis are also easily performed in the zebrafish model. Small, orally active 
drugs can be added directly to the water and are homogeneously and simultaneously 
deliver to a high number of embryos (Kaufman et al., 2009; Jensen et al., 2011). 
The strong similarities between the zebrafish angiogenesis and the mammalian 
counterpart in physiological and pathological conditions has opened promising 
possibilities to model human diseases characterized by angiogenic impairment, and 
mutants resembling human vascular disorders have already been developed. Another 
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interesting application is represented by the modelling of tumor and metastasis 
processes in the zebrafish embryo, for instance after implantation of fluorescently 
labeled mammalian tumor cells in transgenic zebrafish. This permits to follow in vivo 
dynamic aspects of tumor biology such as metastatic cells dissemination and invasion 
(Lee et al., 2009; Rouhi et al., 2010; Jensen et al., 2011). 
 
2.4.2 Wnt pathway, hypoxia, Angiomotins and mevalonate/Rho GTPases signalings: 
possible roads linking YAP/TAZ and angiogenesis 
 
Wnt pathway 
Several knockouts and mutants of Wnt signaling components in animal models 
evidence a role of Wnt pathway in vascular development. Consistently, expression of 
Wnt ligands and receptors, as well as TCF/Lef transcription factors has been observed 
in endothelial cells, and supported by the activation of mouse Wnt/β-catenin reporter in 
the vasculature during embryonic development. The activation of β-catenin in the adult 
vasculature is low, but it has been reported during pathological neovascularization, 
suggesting a function for Wnt/β-catenin signaling in actively growing vessels but not in 
healthy, resting vasculature. Different studies showed a co-operation of Wnt/β-catenin 
and Notch signaling pathways in endothelial cells specification and morphogenesis. 
Moreover, various angiogenic factors, such as VEGF and IL-8, are transcriptionally 
induced by the Wnt/β-catenin signaling (Choi et al., 2012). 
Nevertheless, some contrasting results have also been found, since the Wnt 
antagonists in some cases promoted, in others inhibited angiogenesis. The discrepancy 
is likely due to the fact that different levels of expression of these antagonists have a 
concentration-dependent Wnt regulatory activity (Choi et al., 2012). 
 
Hypoxia 
Hypoxia is an undeniable driving force of angiogenesis in many contexts, ranging 
from developmental angiogenesis to angiogenesis occurring during cutaneous wound 
healing and tumor progression (Jensen et al., 2011; Semenza, 2012; Liao and Johnson, 
2007). 
A very recent work strongly connected hypoxia to the Hippo pathway and YAP 
activity. Specifically, a direct binding between the E3 ubiquitin ligase SIAH2, an 
essential component of the hypoxia response pathway, and LATS1/2 kinases of the 
Hippo cascade was evidenced. Under hypoxia, SIAH2 promoted LATS1/2 
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ubiquitylation and degradation, leading to reduced LATS1/2-mediated YAP 
phosphorylation and increased YAP transcriptional activity. In a breast cancer xenograft 
mouse model, SIAH2 knockdown suppressed tumorigenesis by this mechanism. 
Furthermore, YAP was required for HIF1α accumulation and supported the 
transcription of HIF1α target genes, such as VEGF. The two proteins physically 
interacted in the nucleus and YAP/HIF1α was found at the HRE (hypoxia responsive 
element) site within the VEGF promoter region in response to hypoxia. Consistently, 
YAP knockdown in the same xenograft mouse model impaired HIF1α accumulation 
and reduced microvessel density (Ma et al., 2014) (Figure 2.6 A). 
 
Figure 2.6. Crosstalk between the Hippo/YAP/TAZ and the hypoxia response pathways. (A) 
Proposed model of crosstalk between Hippo/YAP signaling and hypoxia response. Hypoxic signals 
promote YAP nuclear activity via SIAH2-mediated LATS1/2 inhibition. Within the nucleus, YAP binds 
HIF1α and supports its transcriptional activity (From Ma et al., 2014. Reprinted with permission). (B) 
Proposed model of crosstalk between Hippo/TAZ signaling and hypoxia response. As for YAP, hypoxia 
signals promote TAZ nuclear activity (through an unknown mechanism) leading to HIF1α/TAZ binding 
in the nucleus and HIF1α-driven transcription. COX-2 blockade by NS398 inhibitor stimulates LATS-
mediated TAZ phosphorylation and subsequent degradation (From Bendinelli et al., 2013. Reprinted with 
permission). 
 
A similar crosstalk has been reported also between hypoxia and TAZ in bone 
metastasis from breast cancer, although it is not known if the same SIAH2-mediated 
mechanism is involved too. HIF1α and TAZ were found to co-localize in bone 
metastasis specimen. In 1833 bone metastatic cells under hypoxia, HIF1α and TAZ 
levels increased in the nuclei and the two proteins directly interacted, enhancing HIF1α-
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DNA binding. TAZ was found in the specific complex and was able to modulate the 
HRELuc hypoxia reporter expression. Moreover, the inhibition of COX-2 (encoded by a 
HIF1α target gene) prevented HIF1α induction and stimulated LATS-mediated TAZ 
degradation in both 1833 cells and xenograft model, where also a reduction in tumor 
growth was observed (Bendinelli et al., 2013) (Figure 2.6 B). 
The mechanisms and crosstalks described here, however, appear far to be universal 
or unique in the hypoxia response. In fact, another recent work showed how hypoxia 
reduced YAP phosphorylation also in epithelial ovarian cancer cells, consistently with 
the SIAH2-mediated LATS1/2 degradation model, but had an opposite effect on TAZ, 
at least in vitro. Specifically, a potent S69-phosphorylation of TAZ was reported in 
hypoxic conditions in epithelial ovarian cancer, prostate cancer, colon adenocarcinoma 
and breast cancer cell lines, with a mechanism that seamed independent of LATS (Yan 
et al., 2014). 
 
Angiomotins 
Angiomotins were originally identified as angiostatin binding proteins, found 
predominantly expressed in the endothelium and implicated in the regulation of 
endothelial cell migration. Amot knockout mice and Amot knockdown zebrafish exhibit 
impairments of vascular development and of endothelial cells migration (Aase et al., 
2007). Mechanistically, AMOT interacts with a polarity complex regulating cell 
junctions and consisting of RhoA, Patj/Mupp1 and Syx, a RhoA GTPase exchange 
factor (RhoGEF). The complex translocates to the leading edge of migrating cells by 
membrane trafficking, targeting Syx and RhoA to phosphorylated VEGFR2, for 
directional migration guided by EGF and PDGF/VEGF receptor tyrosine kinases 
(Garnaas et al., 2008; Ernkvist et al., 2009; Wu et al., 2011). 
The interconnections between the Angiomotins and YAP/TAZ signaling reported in 
the last years delineate a complex and for some aspects controversial picture. It is clear 
that the Angiomotins directly interact with YAP, TAZ, LATS1/2, MST2, Merlin and 
Kibra proteins (Zhao et al., 2011; Chan et al., 2011; Wang et al., 2011; Oka et al., 2012; 
Hirate et al., 2014; Chan et al., 2013; Adler et al., 2013; Dai et al., 2013; Paramasivam 
et al., 2011; Yi et al., 2011). The first studies depicted the Angiomotins as inhibitors of 
YAP/TAZ activity: AMOTL2 (Angiomotin-like 1) knockdown resulted in YAP 
activation and YAP/TAZ-dependent loss of cell contact inhibition (Zhao et al., 2011); 
overexpression of AMOT and AMOTL1 caused TAZ cytoplasmic retention and AMOT 
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knockdown increased YAP/TAZ target genes expression (Chan et al., 2011); AMOTL1 
and AMOTL2 (Angiomotin-like 2) overexpression favoured YAP cytoplasmic 
localization and AMOTL2 downregulation promoted epithelial-to-mesenchymal 
transition similar to YAP overexpression (Wang et al., 2011; Oka et al., 2012). 
Moreover, AMOT is phosphorylated by LATS downstream of signals such as cell 
adhesion, cytoskeleton remodelling and G-protein-coupled receptors (GPCRs) signaling 
and such phosphorylation promotes AMOT-YAP association and subsequent inhibition 
of YAP biological outcomes. Interestingly, AMOT directly binds F-actin and LATS-
mediated AMOT phosphorylation disrupts this contact. As a consequence, YAP activity 
is inhibited, while, due to the loss of AMOT, F-actin stress fibers and focal adhesions 
decrease leading to inhibition of endothelial cell migration and angiogenesis (Hirate et 
al., 2014; Chan et al., 2013; Adler et al., 2013; Dai et al., 2013) (Figure 2.7 A). 
 
Figure 2.7. Crosstalk between AMOT and the Hippo/YAP pathway. (A) Proposed model of YAP 
negative regulation by AMOT. AMOT phosphorylation by LATS leads to the promotion of AMOT-YAP 
association, with consequent inhibition of YAP activity, and concomitant disruption of AMOT-F-actin 
interaction, with consequent inhibition of cell migration (From Dai et al., 2013). (B) Proposed model of 
YAP positive regulation by AMOT. AMOT binds to YAP, thus preventing LATS-mediated YAP 
phosphorylation, and within the nucleus associates with YAP-TEAD transcriptional complex in 
regulating YAP target genes expression (From Yi et al., 2013. Reprinted with permission from AAAS). 
TJ, tight junction. 
 
This mechanism has been shown to explain the activation and inhibition of the Hippo 
pathway at the early blastocyst stage respectively in the nonpolar inner cells and in the 
polar outer cells (see above). In the adherens junctions of the inner cells AMOT is 
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phosphorylated by LATS, which inhibits the actin-binding activity, thereby activating 
the Hippo pathway. In the outer cells, the cell polarity sequesters AMOT from 
basolateral adherens junctions to apical domains, suppressing the Hippo pathway 
(Hirate et al., 2014). 
A new but contrasting light on AMOT/YAP crosstalk has been shed by a recent 
work. Mice with a liver-specific Amot knockout displayed reduced proliferation and 
tumorigenesis in cancer contexts. Furthermore, AMOT binding to YAP prevented YAP 
phosphorylation by LATS, promoting YAP nuclear translocation. Within the nucleus, 
AMOT was associated with YAP-TEAD transcriptional complex and contributed to the 
regulation of a subset of YAP target genes, suggesting a positive role of AMOT for 
YAP/TAZ function in vivo (Yi et al., 2013) (Figure 2.7 B). 
 
Mevalonate/Rho GTPases signaling 
The mevalonate pathway is a metabolic pathway responsible for the synthesis of 
isoprenoid products of mevalonate, which are cholesterol precursors and substrates for 
protein prenylation, a posttranslational modification essential for multiple cellular 
processes, including cell migration, proliferation and angiogenesis (Figure 2.8). These 
isoprenoids, farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP), 
provide lipophilic anchors essential for cytoplasm-to-membrane translocation of 
respectively Ras and Rho of the GTPase family. This translocation is necessary for Ras 
and Rho to exert their role in cell signaling transduction and in angiogenesis. In 
particular, the translocation of Ras activates the mitogen-activated protein kinase 
(MAPK) and nuclear factor-kappa B (NF-kB) pathways, which play a fundamental role 
in angiogenesis. On the other hand, activated Rho associates with cortical actin and 
stress fibers at the membrane periphery and at the lamellipodia extensions, where it is 
crucial for the organization of the actin cytoskeleton and consequently for cell 
locomotion occurring in processes such as angiogenesis. Treatment with cerivastatin, 
which inhibits the HMG-CoA reductase, an enzyme upstream in the mevalonate 
pathway, has been show to inhibit angiogenesis in vivo. The effect, reversed by GGPP, 
is reached by inducing a delocalization of Rho from cell membrane to the cytoplasm, 
leading to the disruption of skeleton actin stress fibers (Vincent et al., 2001; Vincent, 
2002; Choi et al., 2011). 
A first regulation of YAP/TAZ activity by Rho GTPases was reported in the context 
of YAP/TAZ-mediated transduction of mechanical cues and equated to the effects of 
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Rho over the F-actin cytoskeleton, independently of YAP/TAZ phosphorylation (see 
above) (Aragona et al., 2013; Dupont et al., 2011). Only very recently a regulation of 
YAP/TAZ activity by the mevalonate pathway was reported, which is also Rho-
dependent, but requires the phosphorylation of YAP/TAZ by an unknown kinase 
different from LATS. Mechanistically, the mevalonate pathway provides the GGPP 
essential for Rho GTPases membrane localization and activation. In turn, Rho GTPases 
activate YAP/TAZ signaling by inhibiting their phosphorylation, thus promoting their 
nuclear accumulation and biological activities. Statins like cerivastatin, by delocalizing 
Rho GTPases from the cell membrane, cause YAP phosphorylation and TAZ instability, 
even at doses unable to affect F-actin polymerization (Sorrentino et al., 2014). 
 
Figure 2.8. Schematic representation of the mevalonate pathway. The mevalonate pathway enzymatic 
cascade produces the isoprenoid derivatives of mevalonate farnesyl-PP (FPP) and geranylgeranyl-PP 
(GGPP), required for Ras farnesylation and Rho geranygeranylation (Modified from Sorrentino et al., 
2014. Reprinted with permission). 
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3    MATERIALS AND METHODS 
 
3.1 Animals 
 
The fish were staged and fed according to the methods described by Kimmel et al., 
1995, and maintained in large scale acquaria systems (Aquarienbau Schwarz, 
Göttingen-Germany; ZebTech, TECNIPLAST; Müller-Pfleger). A constant high-quality 
water exchange is guaranteed by recirculation systems with biological filters and a 
reverse osmosis supply. Water temperature (28,5 °C), pH (neutral) and saline 
composition (conductivity between 200 and 400 µS) are maintained constant. Before 
distribution to the tanks, water is sterilized by UV radiation to reduce the infectious 
agents spreading. 
Depending on the number of individuals, the fish are kept in tanks with different 
volumes, ranging from 1 liter for single animals, to 5-10 liters for up to 30 fish. The 
dark-light cycle is based on a photoperiod of 12 hours of light and 12 hours of dark. The 
fish are fed once a day with dry food (TetraMin) and twice with living Artemia salina 
nauplia. Artemia salina is a primitive aquatic arthropod, bought as cysts and raised to 
nauplia stage into inverted cone hatcheries, in appropriate salinity, oxygen and light 
conditions. 
The fish are mated in the late afternoon into 1 liter thanks holding an internal 
removable container with a grid on the bottom. This avoids fish to eat their own eggs 
and permits to collect the eggs from the bottom of the external tank. Male and female 
are kept apart by a plastic transparent separator, which is removed in the morning after 
the light turns on. The eggs are collected with a sieve and transferred in Petri dishes 
containing embryo medium (fish water), where they are incubated at 28,5 °C 
(Westerfield, 2000). At 5-8 hpf unfertilized eggs and dead embryos are selected under 
the dissecting microscope and removed. If they are not fixed or used in some 
experiments, at 6 days post fertilization (dpf) the larvae are transferred into 1 liter 
thanks, with the same medium and temperature, and maintained until 2-3 weeks of age, 
when they are moved to the ZebTech, TECNIPLAST acquaria. From 6 dpf to 2-3 weeks 
zebrafish larvae are fed once a day with dry Artemia powder (Novotom, JBL). 
 
 
40 
 
3.2 Generation of Tg(Hsa.CTGF:nlsmCherry), 
Tg(Hsa.CTGF:eGFP) and Tg(Hsa.CTGF:VenusPEST) lines 
 
The -200/+27-CTGF promoter fragment was amplified by PCR from a human 
genomic DNA using the following oligonucleotides, containing the suitable restriction 
sites for the subsequent clonings: Hsa.CTGF-for (5’- 
TCTAGAAGATCTTCTGTGAGCTGGAGTGTGC-3’) and Hsa.CTGF-rev (5’- 
AAGCTTCCATGGAGCGGGGAAGAGTTGTTGT-3’). The amplified product was 
cloned in the pCR™-Blunt II-TOPO® plasmid (Invitrogen), according to the 
manufacturer’s instructions. The CTGF promoter fragment was then subcloned in the 
pGL3-basic Luciferase Reporter Vector (Promega), for the luciferase assays (see 
below), using the BglII and HindIII restriction enzymes. The same restriction sites were 
also used to finally subclone the fragment into the Gateway 5’ entry vector pME-MCS 
(Invitrogen). The resulting p5E-Hsa.CTGF entry vector was recombined with the 
nlsmCherry, eGFP and VenusPEST-carrying middle entry vectors and the p3E-polyA 
entry clone containing the SV40 late polyA signal (Invitrogen). Entry plasmids were 
recombined into the Tol2 destination vector pDestTol2pA2 (Invitrogen) through a 
MultiSite Gateway LR recombination reaction as previously described (Kwan et al., 
2007). 30 pg of the recombined Tol2 destination vectors with 25 pg of in vitro 
synthesized Tol2 transposase mRNA (Kawakami et al., 2004) were co-injected into 
one-cell stage wild-type zebrafish embryos. 
Microinjected embryos were selected for mosaic transgenic expression at 24 and 72 
hpf using an epifluorescent microscope, raised to adulthood and outcrossed to wild-type 
fish. Overall, 13 out of 17 screened fish were identified as founders. Founder fish for 
each reporter line, Tg(Hsa.CTGF:nlsmCherry), Tg(Hsa.CTGF:eGFP) and 
Tg(Hsa.CTGF:VenusPEST), were selected for fluorescence level and the number of 
transgenic insertions (i.e. for the proportion of the progeny positive for the transgene) in 
their genome or in that of the fish of the following generations, in order to establish 
stable single allele transgenic lines. 
 
 
3.3 Transient Yap/Taz overactivation in the endothelium 
 
Flag-mTAZ-4SA  was  subcloned  in  pME-MCS  (Invitrogen)  from  a  pCS2  vector 
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(Azzolin et al., 2012). MultiSite Gateway LR recombination reaction was performed as 
described above, to recombine the obtained pME-TAZ-4SA, the p5E-fli1a and the p3E-
polyA (Invitrogen) into the Tol2 destination vector pDestTol2CG2 (Invitrogen). 20 to 
40 pg of the recombined Tol2 destination vectors with 25 pg of in vitro synthesized 
Tol2 transposase mRNA (Kawakami et al., 2004) were co-injected into one-cell stage 
Tg(kdrl:GFP) zebrafish embryos. The effect of Yap/Taz transient overactivation in the 
endothelium by TAZ-4SA expression was analyzed at 32 hpf at the confocal 
microscope. 
 
 
3.4 Zebrafish transgenic lines 
 
The following fish lines were used and outcrossed either to wild-type fish or to the 
Tg(Hsa.CTGF:nlsmCherry) Yap/Taz reporter line: Tg(7xTCF-Xla.Siam:GFP)
ia4
 Wnt/β-
catenin reporter (Moro et al., 2012), Tg(hsp70:dkk1-GFP) heat shock inducible Dkk 
overexpressing line (Stoick-Cooper et al., 2007), apc
hu745 
mutant line 
 
(Hurlstone et al., 
2003), Tg(cmlc2:GFP) (Burns et al., 2005), Tg(gutGFP)
s854 
(Field et al., 2003), and 
Tg(kdrl:GFP) (Beis et al., 2005). 
 
 
3.5 Genotyping of APC mutants 
 
apc
hu745 
mutant carriers were genotyped by PCR amplification followed by 
sequencing for the identification of the point mutation (cytosine to timine). Genomic 
DNA was extracted from the tail of adult fish and PCR amplified with the following 
primers: apc-for (5’-CTACCCAACTTTACCTATATCAG-3’) and apc-rev (5’-
GACTCTCAAAACTGTCAAGGG-3’). The PCR product was sequenced using apc-for 
primer and the sequence obtained was analyzed at position 33 downstream of the 
sequencing primer. 
apc
hu745 
mutant carriers were outcrossed to the Tg(Hsa.CTGF:nlsmCherry) Yap/Taz 
reporter line, the progeny was screened for the reporter transgene expression and raised 
to adulthood. The reporter fish were screened for the apc mutation as described and 
incrossed to obtain Yap/Taz reporter embryos in apc homozygous mutant background. 
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Homozygous mutants were selected by the phenotype under the dissecting microscope. 
Wild-type and heterozygous embryos were used as control. 
 
 
3.6 Luciferase assays 
 
Luciferase assays were performed in MDA-MB-231 cells with the established 
YAP/TAZ-responsive reporters 4xGTIIC-Lux and 8xGTIIC-Lux (Dupont et al., 2011) 
and with the novel YAP/TAZ-responsive reporter Hsa.CTGF-Lux, generated in this 
study by cloning the -200/+27-CTGF promoter fragment into the pGL3-basic 
Luciferase Reporter Vector (Promega) (see above). Cell lysates were analyzed using the 
Dual-Luciferase Reporter Assay System (Promega, cod. E1910).  Luciferase reporters 
(50 ng/cm
2
) were transfected together with CMV-β-gal (75 ng/cm2) to normalize for 
transfection efficiency with CPRG (Roche) colorimetric assay. NF2 plasmid was co-
transfected at 50 ng/cm
2
. DNA content in all samples was kept uniform by adding 
pBluescript plasmid up to 250 ng/cm
2
. Cells were plated at 25% confluence (day 0) and 
the next day (day 1) were transfected with DNA. At day 2 cells were washed from 
DNA-transfection medium and harvested after 24 hours (day 3). For luciferase assays in 
siRNA-transfected cells, cells were plated at 20% confluence (day 0) and the next day 
(day 1) were transfected with the indicated siRNAs for no more than 8 hours before 
changing medium. At day 2 cells were transfected with DNA, at day 3 medium was 
changed and cells were harvested at day 4. Where indicated, cells were treated with the 
F-actin inhibitor latrunculin A (Lat.A, 0.5 μM). Each sample was transfected in 
duplicate and each experiment was repeated at least three times independently. 
NF2 is Addgene #19701. Latrunculin A was from Santa Cruz. The sequences of the 
siRNAs used in this study are as follows (sense strand sequences are indicated): 
- YAP 1: GACAUCUUCUGGUCAGAGA dTdT; 
- YAP 2: CUGGUCAGAGAUACUUCUU dTdT; 
- TAZ 1: ACGUUGACUUAGGAACUUU dTdT; 
- TAZ 2: AGGUACUUCCUCAAUCACA dTdT; 
- control: UUCUCCGAACGUGUCACGU dTdT. 
YAP/TAZ siRNA 1 refers to the mix composed of oligos YAP 1 and TAZ 1; 
YAP/TAZ siRNA 2 refers to the mix composed of oligos YAP 2 and TAZ 2. 
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3.7 Morpholinos injections 
 
The antisense morpholino oligos were obtained from Gene Tools, LLV (U.S.). The 
following splice blocking (MO-Yap and MO-Taz) and control morpholinos were used: 
- MO-Yap: 5′-GCAACATTAACAACTCACTTTAGGA-3’; 
- MO-Taz: 5’-GTATGTGTTTCACACTCACCCAGGT-3’; 
- MO-ctrl: 5’-AGAACATAATCAGTAGTGTTCGA-3’. 
For the validation of  the Yap/Taz reporter line, MO-Yap and MO-Taz were co-
injected into one-cell stage Tg(Hsa.CTGF:nlsmCherry) embryos, 0,7-2 ng each per 
embryo, and the effect on the reporter signal was analyzed at 24 hpf at the 
epifluorescent microscope. For the evaluation of the reporter responsiveness in the 
endothelium, 4-6 ng of MO-Yap per embryo were injected into 
Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP) embryos, and the effect on the reporter 
signal was analyzed at 32 hpf at the confocal microscope. To study the effect of 
Yap/Taz knockdown on the developing vascular system, MO-Yap and MO-Taz were 
co-injected into Tg(kdrl:GFP) embryos, 1-3 ng each per embryo, and the vascular 
phenotype was evaluated at 32 hpf at the confocal microscope. 
 
 
3.8 mRNAs injections 
 
pCS2 plasmids containing Flag-TAZ-4SA and TEAD-VP16, and pCSP1 plasmid 
containing Flag-YAP-5SA were a kind gift of Sirio Dupont. Each plasmid was digested 
with a specific restriction enzyme (NotI for Flag-TAZ-4SA and TEAD-VP16, AscI for 
Flag-YAP-5SA) and the genes were transcribed using the SP6 polymerase (AM1340, 
Lifetechnology). 0,2-1,5 pg of TAZ-4SA and TEAD-VP16 mRNAs and 50-100 pg of 
YAP-5SA mRNA per embryo were injected into one-cell stage 
Tg(Hsa.CTGF:nlsmCherry) embryos, Tg(kdrl:GFP) embryos or 
Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP) double transgenic embryos. 
 
 
3.9 Protein extraction and western blot analysis 
 
For protein extraction the embryos were deyolked (deyolking buffer: 55 mM NaCl, 
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1,8 mM KCl, 1,15 mM NaHCO3), washed (washing buffer: 110 mM NaCl, 3,5 mM 
KCl, 2,7 mM CaCl2, 10 mM Tris HCl pH 8,5) and lysed in RIPA buffer (Sigma) 
supplemented with protease and phosphatase inhibitor cocktail (Sigma). Protein 
concentrations were determined using the Bradford assay (BioRad) and western blot 
was performed as in Azzolin et al. (2014). 
Anti-YAP (63.7) monoclonal antibody was from Santa Cruz. Anti-TAZ (560235) 
monoclonal antibody was from BD Bioscience. 
 
 
3.10 Chemical treatments of zebrafish embryos 
 
The following chemical compounds were used: 
- IWR-1 (I0161, Sigma); 
- XAV939 (X3004, Sigma); 
- BIO (B1686, Sigma). 
Tg(Hsa.CTGF:nlsmCherry) embryos were decorionated and exposed to the drugs 
from 24 to 48 hpf in fish water with 2 mM 1-phenyl-2-thiourea (PTU) to inhibit 
pigmentation. The drugs were used at 10 µM for IWR-1 and 5 µM for XAV939 and 
BIO, and the corresponding volume of DMSO, where the three chemicals are 
solubilized, was used in the controls. 
After the treatments, the embryos were either analyzed under the epifluorescent 
microscope or fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4 °C and then 
stored in pure methanol at -20 °C for in situ hybridization.  
 
 
3.11 In situ hybridization and quantification 
 
Whole mount RNA in situ hybridization was performed on embryos pre-fixed in 4% 
PFA in PBS overnight at 4 °C and stored in pure methanol at -20 °C as previously 
described (Thisse et al., 1993). mCherry probe was synthetized from the pME-
nlsmCherry supplied by the Tol2 kit (Invitrogen), which was linearized and transcribed 
with the T7 RNA polymerase using DIG-labeled ribonucleotides. 
Variations in the intensity of in situ hybridization signal were quantified by 
subdividing the embryos of the control and the experimental group on the basis of the 
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signal intensity observed under the dissecting microscope. Three subgroups were made 
(strong, medium and weak), so that the “strong embryos” of the control pool displayed a 
signal intensity comparable to the “strong embryos” of the experimental pool. The 
embryos in each subgroup were counted and the data were plotted in a histogram. 
Contingency analysis were carried out with Prism software (GraphPad). 
 
 
3.12 Alcian blue staining 
 
For cartilage staining, larvae were fixed overnight in 4% PFA in PBS at 4 °C, 
washed in PBS and stained overnight at room temperature in Alcian blue solution (70% 
EtOH, 1% HCl, and 0.1% Alcian blue). Larvae were then cleared in 3% hydrogen 
peroxide and 1% KOH, rinsed in 70% EtOH and whole mounted in 85% glycerol. 
 
 
3.13 Heat-shock treatments 
 
Dkk overexpression in Yap/Taz reporter embryos was obtained by outcrossing the 
Tg(Hsa.CTGF:nlsmCherry) reporter line to the Tg(hsp70:dkk1-GFP) heat shock 
inducible Dkk overexpressing line. The offspring was heat-shocked every 12 hours, 
from 12 to 72 hpf, by replacing the fish water with water preheated to 40 °C and 
incubating the embryos in an air incubator at 37 °C for 1 hour. The embryos were then 
sorted by GFP fluorescence and GFP negative siblings were used as controls. The 
embryos were analyzed under the epifluorescent microscope for mCherry reporter 
fluorescence and then fixed in 4% PFA in PBS overnight at 4 °C and stored in pure 
methanol at -20 °C for in situ hybridization. 
 
 
3.14 Organ dissection and fin surgeries 
 
To analyze the reporter signal in the internal organs of the adult fish, 
Tg(Hsa.CTGF:nlsmCherry) fish were sacrificed and dissected under the epifluorescence 
microscope. The organs were imaged immediately after, either in situ or isolated, with 
conventional fluorescence or confocal microscopy. Imaging of Hsa.CTGF:nlsmCherry 
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signal in the vessels of the caudal fin was performed in vivo in anesthetized fish under 
the epifluorescence microscope. 
For fin regeneration experiments, both Tg(Hsa.CTGF:nlsmCherry) larvae and adult 
fish were anesthetized with tricaine, the tail was amputated using a razor blade and the 
animals were returned to 28,5 °C fish water. Reporter larvae underwent fin primordia 
amputation at 72 hpf and amputated individuals were fixed for in situ hybridization at 
24 and 48 hours post amputation (hpa), together with age-matched uncut controls. 
Regenerating caudal fins of reporter adults were photographed in vivo after anesthesia at 
24 and 48 hpa using brightfield and epifluorescence. 
 
 
3.15 Image acquisition and analysis 
 
Fluorescence was visualized and acquired using the conventional fluorescence 
dissecting microscope Leica M165FC and the confocal microscope Nikon C2 H600L. 
For brightfield and fluorescence imaging with the dissecting microscope, embryos and 
larvae were anesthetized with tricaine and mounted in 2% metilcellulose. For confocal 
imaging, anesthetized embryos and larvae and anatomical samples of adult fish were 
embedded in 1% low melting agarose. The fluorescence was visualized using 488 nm 
(for GFP and VenusPEST) and 561 nm (for mCherry) lasers and 20x or 40x immersion 
objectives (Nikon). 
Fluorescence quantification of the images acquired either with the conventional 
fluorescence or the confocal microscope was carried out using Fiji software. Each 
image, saved as TIFF file and visualized as a RGB color image, was splitted in the three 
color components and only the channel corresponding to the fluorophore of interest was 
kept (red for mCherry, green for GFP and VenusPEST). A threshold was set to have a 
good signal-to-noise ratio and maintained for all the images of the experiment. 
Fluorescence was quantified as integrated density. For fluorescence quantification of 
whole embryos in images acquired at the conventional fluorescence microscope, the 
yolk and yolk extension areas were excluded from the analysis. For the quantification of 
the reporter signal specific of the endothelium, Hsa.CTGF:nlsmCherry reporter 
fluorescence was acquired with the confocal microscope together with the kdrl:GFP 
fluorescence in 32 hpf double transgenic embryos. Fiji software was then asked to filter 
the mCherry signal using the GFP as a mask, to isolate the reporter expression in the 
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endothelium. For each embryo, a confocal Z-stack projection was realized with the 
obtained filtered images. All the projections were finally analyzed as described before, 
by quantifying the fluorescent signal as integrated density. 
Statistical analysis were carried out with Prism software (GraphPad). 
 
 
3.16 Assessment of vascular changes 
 
The defective ISVs sprouting angiogenesis in Tg(kdrl:GFP) Yap/Taz double 
morphants was evaluated at 32 hpf. Only embryos displaying a mild phenotype after 
brightfield observation at the dissecting microscope (i.e. in which the morpholinos are 
working but without a strong alteration of the phenotype) were imaged with the 
confocal microscope, in vivo or after fixation in PFA 1%. Three different parameters 
were then analyzed: the ISVs length, the percentage of complete ISVs, both measured at 
the midtrunk level, and the number of ISVs sprouts, measured at the caudal vein plexus 
(CVP) level. At the midtrunk level we looked at the 9 ISVs pairs corresponding to the 
yolk extension, but only one lane of them (9 ISVs), easily visible in the confocal 
acquisition, was considered for all the measurements. The length of each ISV was 
measured using Fiji software and expressed as percentage of the average ISVs length of 
the controls. The percentage of complete ISVs was calculated as the ratio, multiplied by 
100, between the number of ISVs that at 32 hpf had already reached the roof level, 
starting to form the dorsal longitudinal anastomosing vessel (DLAV), and the total 
number of ISVs taken into consideration. The number of ISVs sprouts at the CVP level 
was obtained by counting all the ISVs (complete or not) sprouting from the dorsal aorta 
caudally with respect to the end of the yolk extension. For each parameter, 7-10 control 
and morphant embryos from two independent experiments were analyzed. 
For the aberrant sprouting phenotype induced by Yap/Taz activity upregulation, 
again only Tg(kdrl:GFP) embryos with a general mild phenotype were considered and 
imaged at 32 hpf with the confocal microscope. The analysis focused on the same 
midtrunk region described before, but took into consideration both the lanes of ISVs. 
For each embryo, all anomalous vessel sprouts from the ISVs were counted, and divided 
into non-anastomosed and anastomosed sprouts, where anastomosed sprouting indicates 
a complete anastomosis between two adjacent ISVs. Data were expressed as number of 
abnormalities per embryo. A total of 51 control, 42 TAZ-4SA, 31 TEAD-VP16, 34 
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YAP-5SA and 16 pDestTg(fli1a:TAZ-4SA)-injected embryos from at least two 
independent experiments each were analyzed. Embryos injected with the 
pDestTg(fli1a:TAZ-4SA) construct were previously screened for cmlc2:eGFP 
expression. 
All statistical analysis were carried out with Prism software (GraphPad). 
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4    RESULTS 
 
4.1 Generation of Yap/Taz zebrafish reporter lines 
 
4.1.1 ctgf promoter contains three Yap/Taz REs and is conserved between zebrafish 
and humans 
 
A Yap/Taz zebrafish reporter line is a transgenic biosensor fish expressing a 
fluorescent protein under the control of regulatory sequences responsive to Yap/Taz 
signaling pathway. Specifically, Yap/Taz-responsive elements (REs) are represented by 
the DNA-binding sites recognized by Tead transcription factors and defined as MCAT 
sequences (AGGAATG) (Farrance et al., 1992). To drive the transcription of their target 
genes, the transcriptional co-activators Yap/Taz bind to Tead, which contacts its DNA-
binding sites located in the regulatory regions of the target genes. 
 
Figure 4.1. ctgf promoter contains three Yap/Taz REs and is remarkably conserved between 
zebrafish and humans. The promotorial region upstream of the 5’UTR (uppercase) of the zebrafish ctgfa 
and human CTGF genes both contain three TEAD DNA-binding sites (YAP/TAZ REs; in light blue) just 
before the TATA box (in yellow). Their sequences, orientation and distances are outstandingly conserved 
between zebrafish and humans. 
 
To design a Yap/Taz-responsive construct, we therefore decided to look at the 
promoter of the most known Yap/Taz target gene: ctgf. By analyzing the promoter of 
the zebrafish ctgfa gene, we noticed that the 219 bp long sequence upstream of the 5’-
UTR contains three MCAT sites just before the TATA box. We then compare this 
sequence with the one of the human CTGF gene promoter and, interestingly, we found 
that its corresponding region upstream of the 5’-UTR contains three MCAT sites too. 
Moreover, the REs sequences, their orientation and the distances among them are 
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remarkably conserved between zebrafish and humans, suggesting an evolutionary 
conserved and fundamental role of this short regulatory region in controlling CTGF 
gene expression in response to YAP/TAZ/TEAD activation (Figure 4.1). 
Thus, we chose to use this YAP/TAZ REs-containing promotorial region of the 
CTGF gene as the YAP/TAZ-responsive element of the reporter transgenic construct. 
With the idea to filter the reporter construct from other different zebrafish-specific 
regulatory elements possibly present in the sequence among the desired MCAT sites, 
instead of the zebrafish one we used the human CTGF gene promoter fragment as 
starting point for the design of the reporter transgene. 
 
4.1.2 Generation of CTGF-based YAP/TAZ reporter constructs 
 
The transgenic construct on which a zebrafish signaling pathway reporter line is 
based is usually composed of three elements: the pathway-responsive fragment 
containing the repeated specific REs; a minimal promoter; a reporter gene. For the 
generation of the YAP/TAZ transgenic reporter construct we simply cloned, upstream 
of the reporter gene, the CTGF gene promoter fragment derived from the human 
genome. This because it contains both the YAP/TAZ REs and the TATA box, that in 
this case acts as a “natural” minimal promoter instead of an artificial one (Figure 4.2). 
 
Figure 4.2. Schematic representation of the Hsa.CTGF-based YAP/TAZ reporter construct. The 
YAP/TAZ-responsive fragment of the construct is derived from the human CTGF promoter. It contains 
the pathway-specific REs MCAT and the TATA box, and regulates the expression of the downstream 
reporter gene. 
 
The -200/+27-CTGF promoter fragment was amplified by PCR from a human 
genomic DNA and initially cloned in the pCR™-Blunt II-TOPO® plasmid. From this 
plasmid it was then cloned in different reporter vectors, first to test the responsiveness 
and specificity of the YAP/TAZ reporter construct in vitro and then to generate the 
transgenic biosensor fish reporting the activity of Yap/Taz in vivo with different 
fluorescent proteins. 
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4.1.3 The Hsa.CTGF-based YAP/TAZ reporter construct specifically reports 
YAP/TAZ activity in vitro 
 
To assess the ability of the Hsa.CTGF-based YAP/TAZ reporter construct to 
specifically report YAP/TAZ activation, we performed a luciferase test in vitro. The 
Hsa.CTGF promoter fragment was cloned from the pCR™-Blunt II-TOPO® plasmid 
into the pGL3 luciferase reporter vector upstream of the luciferase gene, generating the 
YAP/TAZ-responsive reporter Hsa.CTGF-Lux. 
 
Figure 4.3. The Hsa.CTGF-Lux reporter is specific for YAP/TAZ activity. MDA-MB-231 cells, 
expressing high levels of TAZ, were transfected with the indicated siRNAs or plasmids (control is empty 
vector, NF2 is NF2 expression plasmid), or treated with latrunculin A. The panels display the results of 
luciferase tests with the Hsa.CTGF-Lux (A) or the 8xGTIIC-Lux (B) reporters, recording YAP/TAZ-
dependent transcriptional activity. YAP/TAZ siRNAs strongly downregulate the reporter with respect to 
control siRNA. Luciferase expression was also strongly reduced after both NF2-mediated Hippo pathway 
activation and latrunculin A-mediated mechanical pathway inhibition, when compared to transfection 
with empty vector. 4xGTIIC-Lux is equivalent to 8xGTIIC-Lux in reporting YAP/TAZ activity (data not 
shown). 
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When transfected in breast cancer cells expressing high levels of TAZ, the 
Hsa.CTGF-Lux plasmid gave a strong activation of the luciferase reporter gene. To 
demonstrate that the luciferase expression was specifically due to YAP/TAZ activation, 
we downregulated YAP/TAZ activity in different ways and monitored the reporter 
signal. Direct inhibition of YAP/TAZ by siRNA knockdown, activation of the Hippo 
pathway through NF2 and treatment with latrunculin A, an F-actin inhibitor opposing 
the mechanical pathway, were all able to cut down the reporter signal (Figure 4.3 A). 
These results clearly indicate that the Hsa.CTGF-based YAP/TAZ reporter construct is, 
at least in vitro, responsive to and specific for the activation of YAP/TAZ signaling. 
Moreover, the Hsa.CTGF-Lux reporter behaves exactly as the 4x and the 8xGTIIC-
Lux, the classic reporter plasmids commonly used to report in vitro YAP/TAZ activity 
(Mahoney et al., 2005) (Figure 4.3 B). The 4xGTIIC element is also the YAP/TAZ-
responsive fragment used for the generation of the Yap/Taz zebrafish reporters 
published by Miesfeld and Link, (2014). Hence, the Hsa.CTGF-based YAP/TAZ 
reporter construct represents a novel tool to effectively report YAP/TAZ activity, 
prompting its use in vivo for the development of a promising Yap/Taz zebrafish 
reporter. 
 
4.1.4 Development of Tg(Hsa.CTGF:nlsmCherry), Tg(Hsa.CTGF:eGFP), 
Tg(Hsa.CTGF:VenusPEST) Yap/Taz zebrafish reporter lines 
 
With the aim of generating transgenic Yap/Taz reporter constructs suitable for 
injection in the zebrafish embryo, the Hsa.CTGF promoter fragment formerly described 
was used to create the following Gateway destination vectors: 
pDestTg(Hsa.CTGF:nlsmCherry), pDestTg(Hsa.CTGF:eGFP) and 
pDestTg(Hsa.CTGF:VenusPEST). To do this, the Hsa.CTGF promoter fragment was 
first cloned in a Gateway 5’ entry clone (p5E-MCS). The p5E-Hsa.CTGF vector 
produced was recombined together with a middle entry clone, containing the reporter 
gene, and a 3’ entry clone, containing the SV40 late polyA signal (p3E-polyA), in the 
Tol2 transposon backbone pDestTol2pA2 through a MultiSite Gateway LR 
recombination reaction. The reaction was repeated by using each time a middle entry 
clone containing a different reporter gene (pME-nlsmCherry, pME-eGFP and pME-
VenusPEST). Three different Gateway destination vectors were obtained, in which the 
Hsa.CTGF promoter fragment controls the expression of the nlsmCherry, eGFP and 
VenusPEST fluorescent reporter genes, that codes respectively for the nuclear-localized 
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monomeric Cherry protein, the enhanced GFP and the destabilized green fluorescent 
protein Venus (Figure 4.4). 
 
Figure 4.4. Schematic representation of the Hsa.CTGF-based YAP/TAZ reporter transgenes in the 
Gateway destination vectors. The human CTGF promoter fragment (Yap/Taz REs and TATA box) 
controls the expression of three different reporter genes (nlsmCherry, eGFP and VenusPEST). 
 
One-cell stage zebrafish embryos were injected with each destination vector, together 
with the Tol2 transposase mRNA, that catalyzes the random integration of the 
transgenic construct into the zebrafish genome. Mosaic transgenic fish, displaying a 
strong transient fluorescence already at 24 hpf, were selected and raised to adulthood. 
Then, adult potential carriers were outcrossed to wild-type fish and the offspring was 
screened for the expression of the reporter protein. Averagely 75% of the injected fish 
prescreened for mosaic fluorescence were found to transmit the transgene to their 
germline. These identified founders were used to establish the stable reporter lines 
Tg(Hsa.CTGF:nlsmCherry), Tg(Hsa.CTGF:eGFP) and Tg(Hsa.CTGF:VenusPEST). 
All the offsprings from the different founder fish (injected with the same reporter 
transgene and injected with the different ones) shared a similar reporter protein 
expression pattern, displaying strong fluorescence in the same anatomical districts, such 
as the lens and otic vesicles, the heart, the pharyngeal arches, the vasculature. This 
consistency is important to exclude potential genomic positional effects due to the 
insertion of the transgene in different positions of the genome. 
Differences among the three Yap/Taz reporter lines created are visible in terms of 
intensity of the fluorescent signal, more than in terms of pattern of expression. In fact, 
mCherry and eGFP proteins are more stable than the VenusPEST protein, which indeed 
resulted from the fusion of the fluorescent protein Venus with the PEST sequence, that 
confers fast degradation to the fusion protein. VenusPEST transgenic fish permit 
therefore to follow more dynamic changes of the reporter activation. Its expression 
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pattern, at 24 hpf, is similar to the mCherry and eGFP ones, even if the fluorescent 
signal is weaker, while at 48 hpf no Venus expression is easily detectable throughout 
the embryo, probably reflecting a general downregulation of Yap/Taz activity at this 
stage. This is not appreciable with the mCherry and eGFP lines likely because of the 
stability of the amount of fluorescent proteins produced before. At 72 hpf 
Hsa.CTGF:VenusPEST signal is almost exclusively restricted to the pharyngeal arches, 
which is consistently the most strongly activated region also in the mCherry and eGFP 
reporter lines. 
 
 
4.2 Hsa.CTGF-based zebrafish transgenic lines are bona 
fide Yap/Taz reporters 
 
The responsiveness and specificity of the Hsa.CTGF-based reporter construct for 
YAP/TAZ activity has been already shown in vitro. However, we needed to confirm 
that the zebrafish transgenic lines we developed, based on the same reporter construct, 
were able to report also in vivo variations of Yap/Taz activity. To validate the 
Hsa.CTGF-based Yap/Taz zebrafish reporter lines, we used different genetic 
approaches aimed at perturbing Yap/Taz signaling, in order to observe and report 
whether the fluorescent signal varied in a Yap/Taz activity-dependent manner as 
expected. 
 
4.2.1 Morpholino-mediated Yap/Taz knockdown reduces Hsa.CTGF reporter signal 
 
We first knocked down both Yap and Taz by co-injecting in one-cell stage 
Tg(Hsa.CTGF:nlsmCherry) embryos two splice morpholinos, targeting respectively 
Yap and Taz pre-mRNAs. The knockdown of endogenous Yap and Taz proteins was 
confirmed by Western blotting (Figure 4.5). 
 
Figure 4.5. Western blot analysis of Yap and Taz morpholinos. 
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With the amount of morpholinos injected (0,7-2 ng each per embryo), only a slight 
phenotype of kinked notochord was visible at 24 hpf, while mCherry expression was 
significantly reduced throughout the entire embryo with respect to control morpholino 
injected embryos (Figure 4.6), showing that Tg(Hsa.CTGF:nlsmCherry) reporter line is 
able to report in vivo the downregulation of Yap/Taz activity. 
 
Figure 4.6. Morpholino-mediated Yap/Taz knockdown reduces Tg(Hsa.CTGF:nlsmCherry) 
reporter signal. Two splice morpholinos, targeting respectively Yap and Taz pre-mRNAs, were co-
injected in one-cell stage Tg(Hsa.CTGF:nlsmCherry) embryos. The fluorescent reporter expression was 
documented and quantified at 24 hpf. 
 
The same experiment was repeated with Tg(Hsa.CTGF:eGFP) and 
Tg(Hsa.CTGF:VenusPEST) lines, confirming that they are also able to report the 
morpholino-mediated knockdown of Yap/Taz. 
 
4.2.2 Constitutive activation of Yap/Taz-mediated transcription increases Hsa.CTGF 
reporter signal 
 
Three different mRNAs (coding for YAP-5SA, TAZ-4SA, TEAD-VP16 proteins) 
were injected in independent experiments in one-cell stage Tg(Hsa.CTGF:nlsmCherry) 
embryos to upregulate the reporter signal. YAP-5SA is a constitutively active version of 
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the human YAP protein, which has been mutated in its five key serine residues needed 
for the LATS1/2-dependent phosphorylation, that promotes binding to 14-3-3 proteins 
and subsequent YAP sequestration in the cytoplasm. YAP-5SA is therefore resistant to 
the Hippo pathway-mediated negative regulation, leading to YAP constitutive activation 
in the nucleus. Analogously, TAZ-4SA is the constitutively active version of the murine 
TAZ protein, mutated in its four serine residues recognized by LATS1/2 for the Hippo-
dependent phosphorylation. Finally, TEAD-VP16 is a fusion protein of the N-terminal 
region of TEAD transcription factor and the activation domain of herpes simplex virus 
VP16. TEAD-VP16 does not need any transcriptional co-activator such as YAP or TAZ 
to work, leading again to a constitutive transcription of its target genes, independently 
of YAP or TAZ activation. 
 
Figure 4.7. A constitutively active version of YAP increases Tg(Hsa.CTGF:nlsmCherry) reporter 
signal. YAP-5SA mRNA was injected in one-cell stage Tg(Hsa.CTGF:nlsmCherry)  embryos. The 
fluorescent reporter expression was documented and quantified at 24 hpf. 
 
When injecting YAP-5SA mRNA in one-cell stage reporter embryos, 
Hsa.CTGF:nlsmCherry expression was significantly increased in injected embryos 
compared to control embryos (Figure 4.7). This observation was confirmed by injecting 
the mRNA coding for the constitutively active version of TAZ. A strong increase of 
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reporter fluorescence was observed in TAZ-4SA injected embryos compared to controls 
(Figure 4.8). Finally, we injected also the mRNA coding for TEAD-VP16, acting 
downstream of Yap/Taz and directly on the activation of Tead target genes. Again, an 
increased mCherry expression was detected, obtaining in this case the strongest 
upregulation of the reporter fluorescence (Figure 4.9). 
  
Figure 4.8. A constitutively active version of TAZ increases Tg(Hsa.CTGF:nlsmCherry) reporter 
signal. TAZ-4SA mRNA was injected in one-cell stage Tg(Hsa.CTGF:nlsmCherry)  embryos. The 
fluorescent reporter expression was documented and quantified at 24 hpf. 
 
The experiments performed with the constitutively active versions of YAP, TAZ and 
TEAD clearly indicate the ability of Tg(Hsa.CTGF:nlsmCherry) reporter line to signal 
in vivo an increased Yap/Taz activation. 
A similar responsiveness to Yap/Taz activity upregulation, as observed for the 
downregulation, was found also for the other two Yap/Taz reporter lines produced, 
Tg(Hsa.CTGF:eGFP) and Tg(Hsa.CTGF:VenusPEST). 
 
Taken together, all these Yap/Taz knockdown and upregulation experiments 
demonstrate that the Tg(Hsa.CTGF:nlsmCherry), Tg(Hsa.CTGF:eGFP) and 
Tg(Hsa.CTGF:VenusPEST) lines are responsive to Yap/Taz, being able to report in vivo 
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the variations of the signaling pathway nuclear activity. We can therefore conclude that 
these zebrafish transgenic lines are bona fide Yap/Taz reporters. Moreover, 
Tg(Hsa.CTGF:nlsmCherry), Tg(Hsa.CTGF:eGFP) and Tg(Hsa.CTGF:VenusPEST)  
lines revealed to have a good sensitivity in reporting Yap/Taz activity variations, since 
often the positive and negative regulation of the reporter expression has been observed 
in embryos treated with low reagents concentrations, at which they showed no evident 
morphological phenotype. 
 
Figure 4.9. A constitutively active version of TEAD increases Tg(Hsa.CTGF:nlsmCherry) reporter 
signal. TEAD-VP16 mRNA was injected in one-cell stage Tg(Hsa.CTGF:nlsmCherry)  embryos. The 
fluorescent reporter expression was documented and quantified at 24 hpf. 
 
 
4.3 Tg(Hsa.CTGF:nlsmCherry) zebrafish reporter line 
reveals in vivo Yap/Taz activity domains 
 
Hsa.CTGF-based zebrafish transgenic lines have been validated as Yap/Taz reporter 
and represent now a powerful tool to follow in vivo, during development and in 
adulthood, in physiological but also in pathological conditions, the spatio-temporal 
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activation of Yap/Taz/Tead-mediated transcription. Given the importance of Yap/Taz 
signaling in developmental as well as in tumor biology, this possibility could be very 
beneficial to study in vivo Yap/Taz involvement in these processes and it may open new 
insights into known or still undiscovered roles of Yap/Taz. 
We started therefore the characterization of the zebrafish Yap/Taz reporter by 
analyzing the reporter protein expression pattern throughout embryonic and early larval 
development. We initially focused our attention on Tg(Hsa.CTGF:nlsmCherry) 
Yap/Taz reporter line. 
 
4.3.1 Yap/Taz reporter expression is activated maternally 
 
Hsa.CTGF:nlsmCherry fluorescence is ubiquitously detectable at dome stage and 
during epiboly in embryos derived from transgenic females crossed to wild-type fish 
(Figure 4.10). However, no signal is observed at these stages in the offspring of male 
carriers. 
 
Figure 4.10. Yap/Taz reporter expression is activated maternally. (A) 50%-epiboly stage offspring of 
a Tg(Hsa.CTGF:nlsmCherry) female showing the ubiquitous maternally activated Yap/Taz reporter 
fluorescence. (B-B’) Confocal images (lateral (B) and animal pole view (B’)) of a 50%-epiboly stage 
embryo from the same offspring. Scale bar: 100 µm. 
 
This is possibly due to maternal effect: before the midblastula transition at 512-cell 
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stage (2
3
/4 hours after egg fertilization), when zygotic transcription starts, all mRNAs, 
proteins and the other biomolecules in the embryo are maternal products deposited in 
the egg during oogenesis. Thus, the presence of the mCherry protein very early after 
fertilization indicates the Yap/Taz are transcriptionally active during oogenesis, driving 
the transcription of their target genes in the eggs. 
Consistently with the maternal activation of the reporter, Hsa.CTGF:nlsmCherry 
expression is visible in the adult females ovary, which appears as the organ with the 
strongest reporter signal. In particular, mCherry protein is present in the nuclei of the 
oocytes and the accompanying follicle cells (Figure 4.11). 
 
Figure 4.11. Yap/Taz reporter is active in the ovary of adult females. (A) Tg(Hsa.CTGF:nlsmCherry) 
adult female internal organs. A strong reporter expression is detected especially in the ovary. (B) Zoomed 
view of the ovary. mCherry signal is visible in the nuclei (n) of the oocytes at advanced maturation stages 
and in the accompanying follicle cells, arranged in a single layer adjacent to the oocytes (arrowheads). 
 
4.3.2 Yap/Taz reporter signal is widely active in embryonic tissues and organs 
 
Zygotic expression of the reporter protein appears at late somitogenesis. At 20 hpf 
Hsa.CTGF:nlsmCherry signal is widely active across the developing embryo, with the 
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strongest fluorescence localized in the highly proliferating and undifferentiated tail bud 
mesenchyme (Figure 4.12).  
 
 
Figure 4.12. Yap/Taz reporter is widely active during early embryogenesis. In vivo confocal images 
of Hsa.CTGF:nlsmCherry fluorescence at 20 hpf. Yap/Taz reporter is activated early during 
embryogenesis and at 20 hpf is widely active across the embryo. The signal is stronger in the tail bud 
mesenchyme (arrow), which at this stage represents a highly proliferating and undifferentiated region of 
the developing embryo. 
 
At 24 hpf mCherry expression is observed in many tissues and organs, such as the 
eye, the heart, the midbrain-hindbrain boundary (MHB), the rhombencephalon, the 
epidermis, the muscle, the neural tube, the notochord, the floorplate and the vasculature. 
A sustained expression is persistent in these districts even in the later developmental 
stages (Figure 4.13). In the eye the reporter signal is strong in the lens, mainly in the 
external layer of cells, but it is also present in the neural retina. Moreover, the lens 
remains strongly mCherry positive till adulthood (Figure 4.13 A-B). In the dorsal 
portion of the head, two districts are apparent from 24 hpf: the MHB and the 
rhombencephalon. In the rhombencephalic region, in particular, Hsa.CTGF:nlsmCherry 
expression pattern delineates six stripes of cells that seem to follow the metameric 
organization of the rhombomeres (Figure 4.13 C). At 72 hpf, besides the lens, the 
reporter signal is particularly strong in the pharyngeal arches (primarily the mandibular 
one),  the otic vesicle, the pectoral fin and the heart (Figure 4.13 H-I). 
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Figure 4.13. Tg(Hsa.CTGF:nlsmCherry) expression domains. (A) Confocal sagittal section of the eye 
at 24 hpf. Reporter signal is strong in the lens, mainly in the external layer of cells, but it is also present in 
the neural retina. (B) Lens of a Tg(Hsa.CTGF:nlsmCherry) adult fish. Reporter expression in the lens 
persists till adulthood. (C) Confocal Z-stack projection at 48 hpf showing the transgene expression in the 
rhombencephalon (r) and the midbrain-hindbrain boundary (MHB) regions. A pattern of six stripes of 
cells following the metameric organization of the rhombomeres is apparent. (D) Confocal Z-stack 
projection of the trunk at 48 hpf. A complex mCherry expression pattern is visible. (E-F) Sections of the 
Z-stack projection in (D) are shown to highlight reporter activation in the somatic muscle (E) and in the 
floorplate, the neural tube and the notochord (F). mCherry expression in the somatic muscle is visible as 
V-shaped rows of red nuclei. A strong signal is detected in a row of nuclei located between the neural 
tube and the notochord and representing the floorplate. The neural tube is only weakly mCherry positive. 
Below the floorplate, the notochord is expressing mCherry in the nuclei placed just dorsally and ventrally 
with respect to the dark strip of the notochord cells vacuoles. (G) Reporter fluorescence is visible in the 
epidermis along the whole embryo; here in a confocal Z-stack projection of the terminal portion of the tail 
at 48 hpf. (H-I) Confocal Z-stack projections of the rostral region of a 72 hpf reporter embryo. Besides 
the lens, the reporter signal is mostly strong in the pharyngeal arches, especially in the mandibular one, in 
the otic vesicle, in the pectoral fins and in the heart. In the inset, a dorsal view highlighting the mCherry 
expression in the pectoral fins is depicted. r: rhombencephalon; MHB: midbrain-hindbrain boundary. 
Scale bar: 100 μm. 
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mCherry expression in the heart is visible since the heart itself begins to develop and 
persists all lifelong. To confirm the expression in the cardiac progenitors and 
specifically in the cardiomyocytes, we outcrossed the Tg(Hsa.CTGF:nlsmCherry) line 
to the Tg(cmlc2:GFP) line (Burns et al., 2005), whose promoter (cardiac myosin light 
chain 2) drives eGFP expression in these cell types. As indicated by the co-localization 
between mCherry and eGFP at 22 hpf, just prior to heart formation, and later, Yap/Taz 
reporter is active in the cardiac progenitors as well as in differentiated cardiomyocytes 
(Figure 4.14 A-C). Hsa.CTGF:nlsmCherry fluorescence is visible also in the intestinal 
epithelium along the whole intestine. Specific expression in the epithelium of the 
intestine was demonstrated by the co-localization of the Tg(Hsa.CTGF:nlsmCherry) 
and the Tg(gutGFP)
s854
 signals in the double transgenic embryos, where Tg(gutGFP)
s854
 
is a transgenic line known to label the intestinal epithelium (Field et al., 2003) (Figure 
4.14 D-F). 
 
Figure 4.14. Analysis of Tg(Hsa.CTGF:nlsmCherry) reporter activation in the heart and in the 
intestine. (A) Confocal sagittal section of the heart region at 22 hpf. Yap/Taz are active in cardiac 
progenitors, as indicated by the co-localization between Hsa.CTGF:nlsmCherry and cmlc2:GFP just prior 
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to heart formation. (B) Confocal sagittal section of the heart at 48 hpf. mCherry reporter signal is still 
active in differentiated cardiomyocytes (cmlc2:GFP positive cells). (C) Heart of a 
Tg(Hsa.CTGF:nlsmCherry) adult fish. mCherry expression persists in the heart till adulthood, with a 
strong fluorescence detected in the ventricle, a little weaker in the atrium. (D-E) Confocal Z-stack 
projections at 6 days post fertilization (dpf), showing the strong transgene expression in the whole 
intestine. In the merge images below, a single confocal sagittal section is depicted, focusing on the 
reporter expression in the anterior (D) and the mid-posterior intestine (E). (F) Confocal sagittal section of 
the mid-posterior intestine of a 6 dpf Tg(Hsa.CTGF:nlsmCherry)/Tg(gutGFP)
s854 
double transgenic larva. 
The co-localization highlights the reporter activation in the entire intestinal epithelium (GFP positive 
cells). Scale bar: 100 μm. 
 
4.3.3 Yap/Taz reporter signal is active in the endothelium 
 
One of the most interesting body districts in which Yap/Taz reporter is active 
resulted to be the cardiovascular system, since the activation of Hsa.CTGF:nlsmCherry 
signal in the heart, as already shown, as well as in the vascular network, appears when 
these organs start to develop and it is persistent till adulthood. To analyze in more detail 
the reporter expression in the vasculature, Tg(Hsa.CTGF:nlsmCherry) line was 
outcrossed to the Tg(kdrl:GFP) line (Beis et al., 2005), which expresses the GFP in all 
endothelial cells from embryogenesis till adulthood. The co-localization between the 
two signals indicates that Yap/Taz are active in the endothelial cells in the first 
developing vessels and during later development (Figure 4.15 A-D). We also explored 
Yap/Taz reporter activation in the adult vascular system of a 
Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP) double transgenic fish. The co-localization 
was found in the vascular network of all the organs and tissues we looked at, such as the 
brain, the liver, the intestine, the pancreas, the kidney, the trunk musculature and the 
caudal fin (Figure 4.15 E-H). These results indicate a general activation of Yap/Taz in 
the endothelium throughout the body, both during development and in adulthood. 
Among the adult body districts, the caudal fin is surely the one in which the 
distinction between arteries and veins is more apparent, thanks to the transparency of 
the tissues, that makes easy to see in vivo the direction of the bloodstream. Specifically, 
the arteries run in the middle of the bony fin rays, while the veins run laterally and 
adjacent to the bony rays on both sides, with a complex network of smaller blood 
vessels forming the microvasculature of the inter-ray mesenchyme (Huang et al., 2013). 
We observed that the whole vasculature expresses Hsa.CTGF:nlsmCherry in the 
endothelial cells, but, intriguingly, reporter signal in the veins is much stronger than the 
signal in the arteries (Figure 4.15 G-H). 
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Figure 4.15. Analysis of Tg(Hsa.CTGF:nlsmCherry) reporter activation in the endothelium. (A-D) 
Reporter expression in the endothelium during development. (E-H) Reporter expression in the adult 
endothelium. (A) Confocal sagittal section of the trunk of a 20 hpf 
Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP)
 
double transgenic embryo. Yap/Taz are active in the 
endothelial cells in the developing vessels, as shown by the co-localization between the two signals. (B-
D) Confocal Z-stack projections of the head region (side view in (B), dorsal view in (D)) and the trunk 
(C) at 48 hpf. Reporter signal co-localizes with kdrl:GFP expression throughout the embryo. The insets 
represent zoomed views highlighting the co-localization between Hsa.CTGF:nlsmCherry and kdrl:GFP 
signals. (E-F) Confocal Z-stack projection of a section of a double transgenic adult brain (E) and liver (F), 
displaying Yap/Taz reporter activation in the endothelium of respectively the cerebral and epatic vascular 
networks. (G-H) Fluorescent microscope image of a Tg(kdrl:GFP) (G) and a Tg(Hsa.CTGF:nlsmCherry) 
adult caudal fin. Lateral view, anterior to the left, dorsal to the top. Arterial (white arrows) and venous 
(black arrows) bloodstream is indicated. Yap/Taz reporter activity is stronger in the veins running 
laterally to the bony fin rays with respect to arteries inside the bony rays. Scale bar: 100 μm. 
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4.4 Tg(Hsa.CTGF:nlsmCherry) line reports Yap/Taz 
activation during larval and adult fin regeneration 
 
Together with the well-known role that YAP and TAZ play in organ growth control, 
stem cell and cancer biology, emerging evidences and interests are pointing toward their 
involvement in tissue repair and regeneration. Functional studies in mice and in 
Drosophila revealed that YAP/TAZ are essential in the regenerative processes of gut, 
liver, heart and potentially other tissues (Cai et al., 2010; Grusche et al., 2011; Staley 
and Irvine, 2010; Shaw et al., 2010; Karpowicz et al., 2010; Ren et al., 2010; Xin et al., 
2013; Heallen et al., 2013; Lu et al., 2010). Ongoing experiments are demonstrating 
how Yap/Taz promote and are necessary for the regenerative proliferation also after 
adult fin amputation in the zebrafish model (Mateus et al., 2013). 
In the last years, zebrafish has become a powerful model to dissect the genetic 
mechanisms that regulate vertebrate tissue regeneration (Gemberling et al., 2014). This 
is due to its high and diffuse regenerative ability, the accessibility and semitransparency 
of the caudal fin in particular and the growing panel of genetic tools available to label 
different cell populations or to conditionally manipulate gene expression. Moreover, 
recent evidences showed that larval fin regeneration shared similar cellular and 
molecular mechanisms with the adult, opening the road to an even easier and faster way 
to investigate in vivo the complex biology of the regeneration process (Kawakami et al., 
2004; Mathew et al., 2007; Rojas-Muñoz et al., 2009). In such a context, it is easy to 
understand how useful signaling pathway reporter lines are to follow the spatio-
temporal activation of specific pathways and their crosstalk during the regeneration 
processes (Wehner et al., 2014). Thus, we wondered whether the Hsa.CTGF-based 
zebrafish reporter we developed is able to report Yap/Taz activation during fin 
regeneration. Both larval and adult Tg(Hsa.CTGF:nlsmCherry) fin was amputated and 
the reporter signal was analyzed at 24 and 48 hpa. During normal larval development 
the strong mCherry expression in the tail epidermis makes difficult to see directly in 
vivo a possible upregulation of the reporter after fin amputation. Therefore we looked 
by in situ hybridization at the reporter expression in larval amputated fin and uncut 
controls. By 24 hpa we observed a clear signal at the tip of the tail, totally absent in the 
controls, which constitutes the blastema-like region of the regenerating fin. 24 hours 
later the reporter signal had extended also laterally in the mesenchymal cells underlying 
the stump, with a dynamic expression pattern resembling that of raldh2 and wnt5A, key 
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players in the adult fin regeneration and components of  retinoic acid and Wnt signaling 
pathways, respectively (Rojas-Muñoz et al., 2009) (Figure 4.16). 
 
Figure 4.16. Tg(Hsa.CTGF:nlsmCherry) reporter is activated during larval fin primordia 
regeneration. Tg(Hsa.CTGF:nlsmCherry) larvae underwent fin primordia amputation at 72 hpf and in 
situ hybridization for mCherry was performed at 24 and 48 hpa on amputated larvae and age-matched 
uncut controls. In situ signal is localized at the tip of the regenerating fin by 24 hpa, and extends laterally 
in the mesenchymal cells underlying the stump by 48 hpa. Arrows indicate the amputation plane. 
 
As shown before, in the adult fin Hsa.CTGF:nlsmCherry expression is normally 
present in the endothelium of the whole vascular network (Figure 4.15 H). After 
amputation, some new mCherry positive cells appear in the stump within 24 hpa, and 
they are strongly increased in number by 48 hpa (Figure 4.17). At 24 hpa the few new 
mCherry positive cells could simply represent the initial vessel sprouts precursors to the 
anastomosis forming in the following 24 hours (Huang et al., 2013). Nevertheless, at 48 
hpa the region and the time of the reporter activation correspond to those of the 
formation of the blastema, the homogeneous mass of de-differentiated and proliferative 
cells that forms soon after amputation and before the regenerative outgrowth. It was 
shown that the different cell lineages present in the adult caudal fin, including the 
vascular endothelium, retain fate restriction when passed through the regeneration 
blastema (Tu and Johnson, 2011). We did not investigate whether the 
Hsa.CTGF:nlsmCherry positive cells in the blastema represent the whole proliferative 
mass or only the subpopulation of endothelium-derived cells. However, consistently 
with our observations during regeneration of larval fin, Yap/Taz reporter resulted to be 
active in the de-differentiated proliferating cells of the blastema. 
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Figure 4.17. Tg(Hsa.CTGF:nlsmCherry) reporter is activated during adult fin regeneration. The fin 
of an adult Tg(Hsa.CTGF:nlsmCherry) fish was amputated and the reporter signal next to the amputation 
plane (dashed line) was analyzed 24 and 48 hours after the resection. Within 24 hpa, only a few mCherry 
positive cells appear along the amputation plane (arrows), while at 48 hpa the reporter is expressed in 
many cells of the regenerate (to the right of the dashed line), in the region of the regeneration blastema. 
Scale bar: 100 µm. 
 
We conclude that the Tg(Hsa.CTGF:nlsmCherry) reporter is activated during fin 
regeneration. Furthermore, the Hsa.CTGF-based Yap/Taz zebrafish reporter proves to 
be a valuable tool to study Yap/Taz signaling during fin regeneration both in the adult 
fish and in the larval stage. 
 
 
4.5 Yap/Taz reporter activity is regulated by the Wnt/β-
catenin pathway 
 
It was recently shown in vitro that YAP/TAZ activity is also regulated by the Wnt/β-
catenin pathway, through AXIN-mediated sequestration of YAP/TAZ in the β-catenin 
destruction complex (Azzolin et al., 2012; Azzolin et al., 2014). Thus, we wondered 
whether the Wnt/β-catenin-mediated regulation of Yap/Taz activity is functional also in 
vivo during development, and whether the transgenic lines we developed are able to 
report this crosstalk. Hence, we designed a pharmacological/genetic strategy to inhibit 
and activate the Wnt pathway, using the Hsa.CTGF-based Yap/Taz zebrafish reporter as 
a readout of Yap/Taz activation. 
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4.5.1 Pharmacological inhibition of Wnt/β-catenin pathway reduces Yap/Taz reporter 
signal 
 
Wnt/β-catenin pathway inhibition was achieved pharmacologically by using two 
different compound, IWR-1 and XAV939, whose action results in the increase of AXIN 
levels. In particular, they exerted their effects via inhibition of tankyrases 1 and 2 
(TNKS1 and TNKS2). TNKS1/2 bind directly to AXIN proteins and regulate AXIN 
levels via poly-ADP-ribosylation and ubiquitylation  (Fearon, 2009; Huang et al., 2009; 
Hsiao and Smith, 2008; Chen et al., 2009). Importantly, under physiological conditions 
AXIN represents the limiting factor in the β-catenin destruction complex (MacDonald et 
al., 2009). Therefore, AXIN upregulation by IWR-1 or XAV939 blocks β-catenin 
accumulation and the downstream effects of Wnt signaling (Figure 4.18 C). 
 
Figure 4.18. Wnt/β-catenin pathway inhibition via Axin upregulation reduces 
Tg(Hsa.CTGF:nlsmCherry) reporter signal. Tg(Hsa.CTGF:nlsmCherry)  embryos were exposed to 
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IWR-1 or XAV939 from 24 to 48 hpf and the fluorescent reporter expression was documented (A) and 
quantified (B) at 48 hpf. (C) Schematic representation of IWR-1 and XAV939 action on Axin. Axin acts 
as scaffold for the retention, followed by ubiquitylation and degradation, of b-catenin and Yap/Taz in the 
destruction complex, as depicted by Azzolin et al. (2014). 
 
We aimed to see whether IWR-1 and XAV939-mediated increase in Axin levels 
determines in vivo an effect on Yap/Taz transcriptional activity. To do this, we treated 
the Tg(Hsa.CTGF:nlsmCherry) line with the two compounds and looked for variations 
in Yap/Taz activity by evaluating mCherry reporter signal. In embryos exposed to IWR-
1 from 24 to 48 hpf, as well as in embryos exposed to XAV939 for the same time, we 
observed a little but significant decrease in mCherry signal with respect to age-matched 
control embryos treated with DMSO (Figure 4.18). This indicates that inhibition of 
Wnt/β-catenin signaling pathway via Axin upregulation negatively influences Yap/Taz 
nuclear activity in vivo. 
To confirm in our experimental setup the expected action of IWR-1 and XAV939 on 
Wnt/β-catenin pathway, in one of the experiments the drug treatment was performed on 
double transgenic embryos obtained by crossing the Tg(Hsa.CTGF:nlsmCherry) 
reporter line to the Wnt/β-catenin reporter line Tg(7xTCF-Xla.Siam:GFP)ia4 (Moro et 
al., 2012). The decrease of GFP fluorescence in IWR-1 and XAV939 treated embryos 
versus control embryos showed that the two compounds were properly working by 
inhibiting Wnt/β-catenin signaling (data not shown). 
 
4.5.2 Genetic inhibition of Wnt/β-catenin pathway reduces Yap/Taz reporter signal 
 
To confirm the result obtained with IWR-1 and XAV939 compounds, we also tried a 
different, genetic approach to inhibit the Wnt/β-catenin signaling pathway. We used the 
transgenic line Tg(hsp70:dkk1-GFP) (Stoick-Cooper et al., 2007), which expresses the 
upstream Wnt antagonist Dkk1, fused with the GFP, under the control of an ubiquitous 
heat shock inducible promoter (hsp70). By heat shocking the embryos at 42° C, the 
hsp70 promoter is activated, leading to the overexpression of Dkk1, visualized by the 
GFP which it is fused with. Dkk1 antagonizes Wnt pathway upstream with respect to 
IWR-1, XAV939 and the β-catenin destruction complex, acting directly at the level of 
the binding between the Wnt ligands and their receptor LRP6. As a consequence, the 
Wnt signal cannot reach the destruction complex and β-catenin cannot escape from 
ubiquitylation and degradation (Figure 4.19 E). 
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Figure 4.19. Wnt/β-catenin pathway inhibition via Dkk1 overexpression reduces 
Tg(Hsa.CTGF:nlsmCherry) reporter signal. Tg(Hsa.CTGF:nlsmCherry) fish were outcrossed to the 
Tg(hsp70:dkk1-GFP) line and the offspring was heat shocked, leading to the overexpression of the Wnt 
antagonist Dkk1. (A) Representative images of a double transgenic embryo at 72 hpf after Dkk1 
overexpression compared to a sibling that doesn’t carry the hsp70 transgene. Only a slight decrease in 
mCherry intensity was observed, as quantified in (C). (B) In situ hybridization for mCherry showing the 
reduction of mCherry mRNA level after Dkk1 overexpression. The result is quantified in (D). (E) 
Schematic representation of the Wnt/b-catenin pathway inhibition by Dkk1 overexpression. Dkk1 
antagonizes the Wnt ligand binding to its receptor LRP6, blocking the Wnt signal transduction inside the 
cell. 
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We outcrossed the Tg(Hsa.CTGF:nlsmCherry) fish to the Tg(hsp70:dkk1-GFP) line 
and the offspring was heat shocked every 12 hours, from 12 to 72 hpf, in order to 
maintain Dkk1 overexpression over time. After global and sustained induction of Dkk1, 
mCherry intensity was only slightly decreased. We thus decided to look at the mCherry 
mRNA, which is more dynamic with respect to the protein, permitting to appreciate 
subtle variations. In fact, the in situ hybridization for mCherry showed a significant and 
general decrease of the mCherry mRNA level in the embryos that underwent Dkk1 
overexpression when compared with the siblings that didn’t carry the hsp70 transgene 
(Figure 4.19). 
Together with the results obtained with the pharmacological approach, these data 
support the view that Yap/Taz activity is downregulated when the Wnt/β-catenin 
signaling pathway is inhibited upstream or at the level of the β-catenin destruction 
complex. 
 
4.5.3 Pharmacological activation of Wnt/β-catenin pathway increases Yap/Taz 
reporter signal 
 
We then asked whether Wnt/β-catenin signaling pathway is also able to positively 
regulate Yap/Taz reporter activity. To answer this question, we used a chemical 
activator of the pathway, BIO, that works by inhibiting the activity of GSK3, the kinase 
responsible for β-catenin phosphorylation, which drives β-catenin to degradation. By 
blocking β-catenin phosphorylation, BIO promotes its escape from the destruction 
complex and its subsequent nuclear translocation. It was also shown that 
phosphorylated β-catenin bridges TAZ to its ubiquitin ligase for degradation (Azzolin et 
al., 2012). Hence, BIO is expected to promote TAZ escape from the complex too 
(Figure 4.20 A). 
Tg(Hsa.CTGF:nlsmCherry) Yap/Taz reporter embryos were exposed to BIO from 24 
to 48 hpf. The effect on mCherry expression couldn’t be observed as fluorescence levels 
variations in vivo due to the fact that BIO compound is also emitting fluorescence in 
red. To overcome this problem, we analyzed mCherry expression by in situ 
hybridization with the same probe for mCherry mRNA used for the heat shocked Dkk1 
overexpressing embryos. The level of mCherry mRNA was significantly increased in 
embryos treated with the drug compared to DMSO treated control embryos (Figure 
4.20). We can conclude that, also in vivo during development, β-catenin 
phosphorylation has an impact on Yap/Taz transcriptional activity, as revealed by the 
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modulation of Yap/Taz zebrafish reporter signal after inhibition of GSK3-mediated 
phosphorylation of β-catenin. 
 
Figure 4.20. Wnt/β-catenin pathway activation via Gsk3 inhibition increases 
Tg(Hsa.CTGF:nlsmCherry) reporter signal. Tg(Hsa.CTGF:nlsmCherry) embryos were exposed to BIO 
from 24 to 48 hpf. (A) Schematic representation of Wnt/b-catenin pathway activation by BIO. BIO inhibit 
Gsk3-mediated β-catenin phosphorylation, promoting β-catenin and Taz escape from the destruction 
complex. (B) In situ hybridization for mCherry showing the increase of mCherry mRNA level after BIO 
treatment. The result is quantified in (C).  
 
4.5.4 Genetic activation of Wnt/β-catenin pathway increases Yap/Taz reporter signal 
 
A different approach to activate Wnt/β-catenin signaling pathway by blocking the 
destruction complex activity was also tried. We used the zebrafish mutant line apc
hu745
 
(Hurlstone et al., 2003), which carries a mutation in apc gene resulting in a truncated 
protein similar to those observed in human tumors (Hurlstone et al., 2003). The loss of 
the Apc component causes the destabilization of the β-catenin destruction complex, 
with the subsequent release of its components, included β-catenin and, according to the 
model by Azzolin et al. (2014), also Yap/Taz (Figure 4.21 A). 
Tg(Hsa.CTGF:nlsmCherry) Yap/Taz reporter fish were outcrossed to apc
hu745
 mutant 
line, in order to obtain, by incrossing the apc
hu745 
heterozygous mutants 
Hsa.CTGF:nlsmCherry positive of the following generation, Yap/Taz reporter embryos 
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harboring the apc mutation in homozygosis. Of note, apc mutants display an altered 
phenotype, lethal by 96 hpf. Specifically, as revealed by the alcian blue staining, they 
fail to develop the cartilage structures, that are predominant in the pharyngeal arches at 
72 hpf. Tg(Hsa.CTGF:nlsmCherry) Yap/Taz reporter is strongly activated in this region 
in physiological conditions, while an evident reduction of the mCherry expression is 
observed in apc mutant background (Figure 4. 21 B). However, this effect is due to the 
complete lack of the cartilage structures and not to the regulation the β-catenin 
destruction complex exerts on Yap/Taz activity. To analyze this last aspect we are 
interested in, we moved our attention to the other anatomical districts in which the 
reporter is active. In particular, variations in the reporter signal are well evidenced by in 
situ hybridization for mCherry in the head dorsal region, the eye, the otic vesicle and the 
vascular system along the yolk extension. With the exception of the pharyngeal arches, 
a general upregulation of Yap/Taz reporter activity is clear in apc mutant background 
(Figure 4.21 C-D). This result confirms in vivo during development that Yap/Taz 
activity is positively regulated by the activation of Wnt/β-catenin signaling. 
 
Figure 4.21. Tg(Hsa.CTGF:nlsmCherry) reporter activity is increased in apc mutant background. 
(A) Schematic representation of Wnt/b-catenin pathway activation in apc mutant background. The loss of 
Apc destabilizes the destruction complex, leading to the release of its components, included β-catenin and 
Yap/Taz. (B) apc
hu745
 mutants fail to develop any cartilage structure, as evidenced by the alcian blue 
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staining. In consequence of this, as shown by the in situ hybridization for mCherry, the reporter signal 
labelling the pharyngeal arches disappears in apc mutant background, due to the lack of these structures 
themselves. (C) In situ hybridization for mCherry displaying the general upregulation (with the exception 
of the pharyngeal arches) of Yap/Taz reporter activity in apc mutant background. The increase of 
mCherry mRNA level is evident in the head dorsal region, the eye, the otic vesicle and the vascular 
system along the yolk extension, as indicated by the arrows. (D) Quantification of the results obtained by 
in situ hybridization, showing the increase in Yap/Taz reporter activity in apc mutant background. 
 
Different approaches with chemical compounds, transgenic and mutant lines were 
used both to inhibit and activate Wnt/β-catenin signaling at different levels of the 
pathway. By using the Hsa.CTGF-based Yap/Taz zebrafish reporter as a readout of 
Yap/Taz activation, we showed in vivo during development that Yap/Taz/Tead 
transcriptional activity is regulated both positively and negatively by Wnt signaling. 
Specifically, when acting on the β-catenin destruction complex – primarily, as we did 
with IWR-1, XAV939, BIO drugs and with apc mutants; or upstream in the signaling 
cascade, as in the case of Dkk1 overexpressing transgenics – any alteration of its 
activity resulted in a variation of Yap/Taz reporter signal. The direction of Yap/Taz 
activity variation followed that of β-catenin: the inhibition of Wnt/β-catenin signaling 
(via IWR-1, XAV939 and Dkk overexpression) determined an inhibition of Yap/Taz 
reporter expression, while, on the contrary, Wnt/β-catenin signaling activation (via BIO 
and Apc knockout) determined an increase of Yap/Taz reporter signal. All these results 
are in agreement with the last model depicted in vitro, that places Yap/Taz as integral 
components of the β-catenin destruction complex (Azzolin et al., 2014), and thus 
confirm in a living model such as zebrafish the Wnt/β-catenin-mediated regulation of 
Yap/Taz nuclear activity. 
 
 
4.6 Yap/Taz nuclear activity promotes vessel sprouting 
cell-autonomously 
 
As shown, one of the few tissues in which Yap/Taz reporter signal is strongly 
activated during early development and regeneration and persists throughout the 
development and in adulthood is the endothelium. The role of Yap/Taz in the 
endothelium is almost unknown, so we decided to explore the possible function of 
Yap/Taz in this tissue during development by taking advantage of the observations 
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derived from the Hsa.CTGF-based zebrafish reporter and of the genetic tools available 
for in vivo studies in the zebrafish model. 
 
4.6.1 Hsa.CTGF:nlsmCherry signal in the endothelium is bona fide reporting 
Yap/Taz activity 
 
Before to consider the functional reason why Yap/Taz are active in the endothelium, 
we wanted to confirm that the Hsa.CTGF:nlsmCherry signal is bona fide reporting 
Yap/Taz activity also specifically in this tissue. We have previously demonstrated that 
the Hsa.CTGF-based transgenic fish is a good readout of Yap/Taz activity, as the 
reporter protein expression can be up- and down-modulated as expected by perturbing 
Yap/Taz signaling. However, all these validation experiments were performed and 
analyzed at the organism level, without taking into account each different organ and 
tissue labelled by the reporter. Hence, we focused on the reporter signal in the 
endothelium, to confirm that it also varied in a Yap/Taz activity-dependent manner, as it 
happens for the total reporter signal in general. 
Tg(Hsa.CTGF:nlsmCherry) fish were outcrossed to the Tg(kdrl:GFP) line labelling 
the endothelium and the offspring was injected at one-cell stage with either the splice 
morpholino targeting Yap pre-mRNA or the mRNA coding for the constitutively active 
version of Yap YAP-5SA, that work respectively by knocking down and upregulating 
Yap activity. Hsa.CTGF:nlsmCherry reporter fluorescence was acquired with the 
confocal microscope together with the kdrl:GFP fluorescence at 32 hpf in the midtrunk 
region. Fiji program was then asked to filter the mCherry signal using the GFP as a 
mask, to isolate the reporter expression in the endothelium. The intensity of 
fluorescence was quantified as usual and compared with the endothelium-specific 
mCherry signal of control injected Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP) embryos. 
A significant decrease of the reporter signal in the endothelium was detected after Yap 
morpholino injection compared to controls; on the contrary, a significant increase was 
observed after YAP-5SA mRNA injection (Figure 4.22). The system is quite sensitive, 
considering that the expected variations in the reporter expression were obtained by 
knocking down only Yap and conversely by injecting a dose of YAP-5SA mRNA 
causing only a mild phenotype. 
These results confirm that Tg(Hsa.CTGF:nlsmCherry) reporter line represents a 
specific readout for Yap/Taz activity also in the single endothelial tissue. Consequently, 
we conclude that the constitutive mCherry expression we see in the endothelium is 
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reporting a sustained transcriptional activity of Yap/Taz, suggesting a possible role of 
Yap/Taz signaling during the development and the maintenance of the vascular system. 
 
Figure 4.22. Hsa.CTGF:nlsmCherry signal in the endothelium is bona fide reporting Yap/Taz 
activity. (A, C) Confocal Z-stack projections of the midtrunk region of 32 hpf 
Tg(Hsa.CTGF:nlsmCherry)/Tg(kdrl:GFP) embryos. Lateral view, anterior to the left, dorsal to the top. 
Only mCherry reporter fluorescence in the endothelium is depicted. The images were obtained by 
isolating the reporter signal co-localizing with the kdrl:GFP from the reporter signal in the surrounding 
cells. (A) Yap knockdown by morpholino injection reduces Hsa.CTGF:nlsmCherry expression in the 
endothelium. The reduction of mCherry fluorescence intensity is quantified in (B). (C) Yap activity 
upregulation by YAP-5SA mRNA injection increases Hsa.CTGF:nlsmCherry expression in the 
endothelium. The increase of mCherry fluorescence intensity is quantified in (D). Scale bar: 100 µm. 
 
4.6.2 Yap/Taz knockdown impairs intersegmental vessels (ISVs) growth 
 
With the aim to see whether the perturbation of Yap/Taz activity has some effects on 
the vasculature during embryonic angiogenesis, we first knocked down Yap and Taz by 
morpholino injection in one-cell stage Tg(kdrl:GFP) embryos. Two considerations are 
needed: first, morpholino oligos are working everywhere in the embryo, without any 
specificity for the vascular system; second, the general downregulation of Yap/Taz has 
a very strong impact on zebrafish development (Hong et al., 2005; Khuchua et al., 2006; 
Jiang et al., 2009; Hu et al., 2013), given its fundamental role in regulating stemness, 
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proliferation, cell death and cell-fate decisions. Thus, to avoid a generalized 
developmental impairment, the experiment was performed by injecting an amount of 
morpholinos (1-3 ng each per embryo) that gives rise to a mild phenotype. The 
development of the vascular system was followed by looking in particular at the ISVs 
from 24 to 32 hpf. This time interval corresponds to the midtrunk ISVs growth, from 
their sprouting from the dorsal aorta (DA) to the formation of the DLAV. 
 
Figure 4.23. Yap/Taz knockdown by Yap and Taz morpholinos co-injection impairs ISVs growth. 
(A-D) Confocal Z-stack projections of Tg(kdrl:GFP) 32 hpf embryos. Lateral view, anterior to the left, 
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dorsal to the top. (A-B) Midtrunk region. Representative images of a control (A) and a Yap/Taz morphant 
embryo (B). The dorsal roof level, corresponding to the developing DLAV, is depicted (dashed line). The 
ISVs of the double morphant embryo display a delay in reaching this level. The asterisks indicate the 
ISVs stalled at mid-somite and shorter than the next ones (i.e. more caudal ones), showing a defect in the 
temporal order of the ISVs growth. (C-D) CVP region. Representative images of a control (C) and a 
Yap/Taz morphant embryo (D). The number of the ISVs sprouts (arrows) in this region is reduced in 
Yap/Taz morphants (only the lane of ISVs sprouts of one side of the embryo was considered). Again, 
their reciprocal length is less uniform in the morphants with respect to the controls. (E-G) Quantification 
of the ISVs angiogenesis impairment caused by Yap/Taz knockdown. Only embryos with a mild 
phenotype were considered. In the midtrunk region the length of the single ISVs (E) and the percentage of 
ISVs reaching the dorsal roof level (complete ISVs) (F) were evaluated. In the CVP region the number of 
ISVs sprouts was counted (G). All the three parameters are reduced by Yap/Taz knockdown. ISV, 
intersegmental vessel; DLAV, dorsal longitudinal anastomosing vessel; DA, dorsal aorta; CVP, caudal 
vein plexus. Scale bar: 100 µm. 
 
A general delay in ISVs development was noticed in the double morphant embryos 
with respect to age-matched embryos injected with a control morpholino. At 32 hpf, 
when almost all the ISVs of the midtrunk region in the controls had already reached the 
dorsal roof level (corresponding to the developing DLAV), Yap/Taz morphants 
presented many ISVs that had not (Figure 4.23 A-B). Moreover, normal ISVs growth 
starts rostrally and continues toward the tail, so that the growth of each ISV is time-
shifted with respect to the rostral adjacent one. Besides the simple developmental delay, 
Yap/Taz morphants showed some defects in the temporal order of the ISVs growth, as 
often we found ISVs shorter than the next ones (i.e. more caudal ones) (Figure 4.23 B, 
D). The defective ISVs sprouting angiogenesis was evaluated and quantified at 32 hpf 
by using three different parameters and by focusing on two different anatomical regions. 
At the midtrunk level (corresponding to the yolk extension region), we measured both 
ISVs length and the percentage of complete ISVs, meaning the ISVs that had already 
reached the dorsal roof level and had started to form the DLAV. We moved then 
caudally, at the level of the CVP, where at 32 hpf the last ISVs are sprouting, and we 
evaluated the number of ISVs sprouts per embryo. A significant decrease of all the three 
parameters considered was found in Yap/Taz morphant embryos when compared to 
controls, supporting the observation that Yap/Taz knockdown impairs ISVs growth 
along the trunk (Figure 4.23 E-G). 
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4.6.3 The upregulation of Yap/Taz/Tead-mediated transcription causes aberrant 
vessel sprouting 
 
To further investigate the role of Yap/Taz in embryonic angiogenesis and specifically 
during ISVs growth, we upregulated Yap/Taz activity by injecting TAZ-4SA mRNA in 
one-cell stage Tg(kdrl:GFP) embryos. Again, due to the diffuse and strong action of this 
mRNA, as we did for the morpholinos, the experiment was performed by injecting a 
small amount of mRNA, such that only embryos with a mild general phenotype were 
analyzed. We then looked at the developing vascular system labeled by the kdrl:GFP 
expression, comparing its morphology in TAZ-4SA injected embryos with that in 
control injected embryos. 
Interestingly, at 32 hpf we observed the appearance of anomalous sprouts emerging 
from some ISVs in TAZ-4SA injected embryos. The sprouts arose from around the 
middle of the ISVs and not from the tip cells of the developing ISVs, that at this stage 
had already anastomosed with the tip cells of the ISVs nearby to form the DLAV 
(Figure 4.24 A-B). The supernumerary sprouts pointed mostly toward the adjacent 
ISVs, and often gave raise to complete anastomosis between two adjacent ISVs of the 
same side of the trunk (Figure 4.24 B-C). Despite we reported this aberrant vessel 
sprouting in TAZ-4SA injected embryos with a low frequency with respect to the 
number of the ISVs, this phenomenon is almost absent during normal development. In 
particular, complete anastomosis between adjacent ISVs, like the ones described here, 
were never detected in more than 50 control embryos analyzed and represent a more 
clearly defined phenotype caused by TAZ-4SA injection (Figure 4.24 D-E). We 
therefore decided to focus on this peculiar phenotype; for the following experiments, we 
will show only evaluation and quantification of complete anastomosis between adjacent 
ISVs. The low frequency of the aberrant sprouting phenotype is likely due to the limited 
level of Yap/Taz upregulation we were forced to keep when using a non-tissue-specific 
upregulation system like the mRNA injection. 
To confirm that the aberrant sprouting phenotype was specifically due to Yap/Taz 
overactivation, ruling out any possible side-effect of TAZ-4SA mRNA, the experiment 
was repeated using YAP-5SA mRNA instead of the TAZ-4SA one. Again, we obtained 
the same phenotype observed before (data not shown). Moreover, we asked whether the 
effect on ISVs angiogenesis we reported was due to the enhanced Yap/Taz/Tead-
mediated transcription, as expected, or to other different actions of Yap and Taz 
proteins. To address this issue, Tg(kdrl:GFP) embryos were injected with TEAD-VP16 
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mRNA, which constitutively activates Tead target genes transcription independently of 
Yap/Taz. Aberrant vessel sprouting and anastomosis between ISVs were found also 
after the injection of TEAD-VP16 mRNA alone, thus confirming the vessel sprouting-
promoting capacity of forced Yap/Taz/Tead-mediated transcription (Figure 4.25 C and 
data not shown). 
 
Figure 4.24. Yap/Taz activity upregulation by TAZ-4SA mRNA injection causes aberrant vessel 
sprouting. (A-C) Confocal Z-stack projections of the midtrunk region of Tg(kdrl:GFP) 32 hpf embryos. 
Lateral view, anterior to the left, dorsal to the top. Representative images of a control (A) and two TAZ-
4SA mRNA injected embryos, showing an aberrant ISV sprout from one ISVs (arrowhead in (B)) and an 
anastomosis between adjacent ISVs (arrowhead in (C)). (D-E) Quantification of the aberrant sprouting 
caused by Yap/Taz activity upregulation. Only embryos with a mild phenotype and ISVs of the midtrunk 
region were considered. The number of non-anastomosed aberrant sprouts and the number of anastomosis 
between adjacent ISVs were evaluated. Both phenomena, observed in TAZ-4SA mRNA injected 
embryos, are extremely rare or absent at all in the controls. ISV, intersegmental vessel; DLAV, dorsal 
longitudinal anastomosing vessel. Scale bar: 100 µm. 
 
4.6.4 The vessel sprouting-promoting capacity of Yap/Taz is cell-autonomous 
 
As already said, TAZ-4SA mRNA, as well as the other mRNAs used to upregulate 
Yap/Taz transcriptional activity, is expected to diffuse everywhere in the embryo, 
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without any specificity for a cell type, an organ or a tissue. Thus, even though we 
analyzed the effects of Yap/Taz upregulation in the vascular system, the surrounding 
tissues were also undergoing the same upregulation. This raised the issue of what tissue 
is responsible for the aberrant vessel sprouting phenotype we observed in the 
vasculature. Is the overactivation of Yap/Taz in the endothelial cells enough to promote 
the supernumerary ISVs sprouts? Otherwise, is the phenotype a secondary effect due to 
the general Yap/Taz overactivation in the surrounding tissues or maybe to the paracrine 
action of a specific tissue nearby the endothelium? To answer these questions and prove 
if the vessel sprouting-promoting capacity of Yap/Taz is cell-autonomous or not, we 
designed a new transgenic construct, placing TAZ-4SA expression under the control of 
the fli1a promoter. TAZ-4SA-coding sequence was first cloned in a Gateway middle 
entry clone (pME-MCS). The pME-TAZ-4SA vector produced was recombined 
together with the 5’ entry clone containing the fli1a promoter (p5E-fli1a) and the 3’ 
entry clone p3E-polyA in the Tol2 destination vector pDestTol2CG2. The final product 
of the MultiSite Gateway LR recombination reaction was the destination vector 
pDestTg(fli1a:TAZ-4SA), which drives the expression of the constitutively active TAZ 
in all endothelial cells, but not in the surrounding tissues. The pDestTol2CG2 Tol2 
transposon backbone used contains the cmlc2:eGFP transgenesis marker, which 
expresses the eGFP in the cardiomyocytes carrying the transgene. Considering that the 
cmlc2:eGFP transgene is placed in the same vector of the fli1a:TAZ-4SA transgene, the 
extension of eGFP expression in the cardiac muscle represents an estimation of the 
degree of the mosaicism in transiently injected mosaic fish. 
The pDestTg(fli1a:TAZ-4SA) vector was injected in one-cell stage Tg(kdrl:GFP) 
embryos together with the Tol2 transposase mRNA and the effect of Yap/Taz transient 
overactivation in the endothelium was analyzed. Unfortunately, the degree of the 
mosaicism was estimated to be extremely low, because only a few eGFP positive 
cardiomyocytes were found in the heart of the injected embryos. We supposed a toxicity 
problem of the vector itself, since an higher dosage strongly increased the mortality rate. 
Nevertheless, we speculated that, although TAZ-4SA was expressed only in a few ISVs 
endothelial cells, if the vessel sprouting-promoting capacity of Yap/Taz is cell 
autonomous, we expected to observe anyway the aberrant sprouting phenotype, at least 
in some ISVs. We thus screened the injected embryos for mosaic cmcl2:eGFP 
expression and analyzed the vasculature morphology in the midtrunk region. About 
60% of the cmlc2:eGFP mosaic expressing embryos do not display any alteration, 
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possibly due to complete or nearly complete absence of endothelial cells carrying the 
transgenic construct and expressing TAZ-4SA protein. However, the remaining 
embryos showed the peculiar anastomosis between ISVs observed after TAZ-4SA, 
YAP-5SA and TEAD-VP16 mRNAs injection, up to four anastomosis in a single 
embryo (Figure 4.25). Therefore, the upregulation of Yap/Taz nuclear activity only in 
the endothelium is sufficient to phenocopy the aberrant vessel sprouting effect caused 
by TAZ-4SA, YAP-5SA and TEAD-VP16 mRNAs injection, indicating that the vessel 
sprouting-promoting capacity of Yap/Taz/Tead-mediated transcription is cell-
autonomous. 
 
 
Figure 4.25. Yap/Taz activity upregulation only in the endothelium by fli1a:TAZ-4SA phenocopies 
the aberrant vessel sprouting caused by TAZ-4SA and TEAD-VP16 mRNAs injection. (A-B) 
Confocal Z-stack projections of the midtrunk region of Tg(kdrl:GFP) 32 hpf embryos. Lateral view, 
anterior to the left, dorsal to the top. Representative images of a control (A) and a fli1a:TAZ-4SA mosaic 
expressing embryo (B) showing three anomalous anastomosis between adjacent ISVs (arrowheads). (C) 
Quantification of the anastomosis between ISVs observed in TAZ-4SA mRNA (see also Figure 4.24), 
TEAD-VP16 mRNA and pDestTg(fli1a:TAZ-4SA) DNA injected embryos. Scale bar: 100 µm. 
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Overall, our observations in vivo in the Hsa.CTGF-based Yap/Taz zebrafish reporter 
and in Tg(kdrl:GFP) embryos after different perturbations of Yap/Taz activity suggest a 
new role of this signaling pathway in embryonic angiogenesis. Specifically, Yap/Taz 
are necessary for the proper growth of the ISVs, since Yap/Taz downregulation impairs 
their growth. Oppositely, forced Yap/Taz/Tead-driven transcription is able to cell-
autonomously promote aberrant sprouting of endothelial cells from the ISVs and the 
formation of complete anastomosis between adjacent ISVs never detected during 
normal development. 
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5    DISCUSSION 
 
5.1 A novel Yap/Taz zebrafish reporter 
 
YAP/TAZ signaling has recently gained a central position in developmental, cancer 
and regeneration biology; the intense research of the last years is unravelling novel 
views on YAP/TAZ biology and exciting therapeutic perspectives are emerging. 
Nevertheless, our knowledge in the complexity of YAP/TAZ signaling is still limited, 
starting from the spatio-temporal pattern of YAP/TAZ activity during development and 
in adulthood. Here, we described the generation, validation and characterization of a 
Yap/Taz zebrafish reporter, which represents an initial but powerful answer to this 
issue, allowing to follow the signaling activity in the living organism. 
Validation through knockdown and overexpression approaches showed that the 
Hsa.CTGF-based zebrafish transgenic lines we developed effectively reports in vivo 
Yap/Taz activity, being able to reflect variations in the signaling with a good sensitivity. 
Another Yap/Taz zebrafish reporter was published last year by Miesfeld and Link 
(2014), based on a different transgenic construct. To drive the expression of the reporter 
gene in the districts of Yap/Taz transcriptional activity, we used a fragment of the 
promotorial region of the Yap/Taz target gene CTGF, containing 3 Yap/Taz REs and 
the TATA box as minimal promoter. Miesfeld and Link, instead, used the established 
4xGTIIC promoter, containing 4 artificially multimerized Yap/Taz REs (Mahoney et al., 
2005), followed by the minimal promoter of the chicken troponin T (cTNT) gene, a 
transcriptional target of TEAD. Besides the comparison among the progenies of 
different founder fish, the comparison among reporter lines of the same signaling 
pathway but based on a different design of the transgenic construct is an important step 
in the validation of a novel zebrafish reporter line. In this case, in fact, the consistency 
of the reporter expression pattern represents a strong indication of the responsiveness of 
the transgenic fish to the specific pathway, independently of other factors possibly 
linked to the particular transgenic construct used  (Shimizu et al., 2012). 
The expression of the 4xGTIIC reporter was described in the epidermis, the heart (in 
cardiac progenitor cells as well as in differentiated cardiomyocytes), the otic and lens 
vesicles, the midbrain-hindbrain boundary (MHB) region and the striated muscle of the 
trunk (Miesfeld and Link, 2014). The Hsa.CTGF-based reporter presented in this thesis 
also displays a strong expression of the reporter protein in these districts. This confirms 
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the specificity of the reporter line for the pathway of interest and highlights relevant 
tissues of Yap/Taz activity, suggesting that this signaling may have there an important 
functional role during development. 
Nevertheless, some differences in the reporter expression pattern are apparent 
between the two reporters. From 24 hpf, Hsa.CTGF:nlsmCherry expression is detected 
also in the rhombencephalon, the neural tube, the notochord, the floorplate and the 
vasculature and at 72 hpf the reporter signal is particularly strong in the pharyngeal 
arches and in the pectoral fin too. All these anatomical domains of expression are not 
described for the 4xGTIIC transgenic. Overall, the Hsa.CTGF-based reporter displays a 
much wider expression pattern, whilst that of the 4xGTIIC one is restricted to a few 
organs and tissues, with the reporter gene predominantly expressed in the skeletal and 
cardiac muscle. These differences might be ascribed to unknown signals derived from 
the cTNT minimal promoter contained in the 4xGTIIC reporter construct, since the 
TEAD target gene cTNT is specifically expressed in both embryonic skeletal and 
cardiac muscle. It is important to note, however, that elements conferring muscle 
specificity to cTNT expression have been found in the sequences flanking the MCAT 
core motifs (Larkin et al., 1996), located upstream of the cTNT promoter fragment 
probably used as minimal promoter by the authors, and thus not present in the 4xGTIIC 
reporter construct. 
On the other hand, one could argue that the Hsa.CTGF-based lines might report the 
zebrafish ctgf gene expression pattern instead of Yap/Taz signaling activity, and this 
might explain the differences with the 4xGTIIC Yap/Taz reporter. There are several 
reasons to exclude this hypothesis: i) the reporter expression is driven by a 200 bp 
fragment of the CTGF promoter, that represents only a minimal part with respect to the 
whole promoter regulating the expression of the CTGF gene; ii) we used the human 
CTGF promoter, in order to filter the reporter construct from other zebrafish-specific 
regulatory elements possibly present in the sequence among the desired MCAT sites; 
iii) the reporter expression pattern is not overlapping the ctgf one, neither represents a 
subset of it; iv) the ctgf and the reporter protein expression are not co-regulated. As 
expected by the fact that ctgf is a Yap/Taz target gene, there is a considerable overlap 
between the ctgf and the reporter expression during development, especially in the 
districts showing the strongest signals, such as the lens and otic vesicles, the heart, the 
pharyngeal arches, the pectoral fin, the floorplate. However, the Hsa.CTGF-based 
Yap/Taz reporter is also active in regions in which the ctgf expression is off: the 
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endothelium, the intestine, the epidermis, the MHB and the rhombencephalic regions. 
Moreover, we experimentally observed that in certain conditions the ctgf and the 
Hsa.CTGF reporter gene are not co-regulated, thus ruling out the hypothesis of dealing 
with a ctgf expression reporter instead of a Yap/Taz activity reporter. For example, 
treatment with either IWR-1 or XAV939 leads to a general downregulation of the 
reporter signal, but a concomitant upregulation of the ctgf expression, as assessed by in 
situ hybridization (data not shown), possibly due to other regulations impacting on the 
ctgf expression independently of Yap/Taz and acting on regulatory sequences other than 
the MCAT sites. Of note, CTGF is a well-known YAP/TAZ target gene and a good 
readout for YAP/TAZ activity in cultured cells and in mice, but studies validating the 
CTGF as a general readout of YAP/TAZ activity in vivo during development are still 
absent. 
To further validate the Hsa.CTGF reporter, we evaluated the consistency of the 
reporter gene expression pattern with that of yap and taz described in the literature. It is 
important to underline here that the Yap/Taz reporter we developed is reporting the 
transcriptional activity of Yap/Taz, not their simple expression pattern as it could be 
analyzed by in situ hybridization. In fact, the presence of Yap/Taz proteins in the cell 
doesn’t automatically mean a Yap/Taz activity inside the nucleus, given the prominent 
post-translational regulation that governs their nucleocytoplasmic shuttling. In 
zebrafish, yap is ubiquitously expressed at 6-somite stage; as development progresses, 
yap expression is associated to several tissues and organs, mainly the notochord, the 
brain (evident in particular at the level of the MHB and the rhombomeres), the eye, the 
branchial arches and the pectoral fins (Jiang et al., 2009). Similarly to yap, taz is 
ubiquitously expressed at early stages. At 24 hpf, an high expression is visible in the 
head, the eye and the tail, becoming restricted to the head, the eye, the heart and the 
endodermal tissue next to the yolk by 30 hpf. A general downregulation of both yap and 
taz expression is evident at 50-60 hpf. Overall, yap/taz expression pattern is consistent 
with the Yap/Taz activity pattern revealed by the Hsa.CTGF reporter. The strong 
downregulation and the restriction of the reporter activity pattern evidenced by the 
Tg(Hsa.CTGF:VenusPEST) line at 48 hpf probably reflect those of yap/taz expression. 
As already touched on, this is not appreciable with the  mCherry and eGFP lines, likely 
because of the difference in the proteins half-life. 
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5.2 In vivo analysis of Yap/Taz activity 
 
The first important application of the newly generated Hsa.CTGF-based Yap/Taz 
reporter is represented by the investigation of the spatio-temporal activation of Yap/Taz. 
A zebrafish biosensor like the one presented in this thesis enables to follow in vivo at 
single-cell resolution the activity of the signaling pathway during embryonic and larval 
stages of development, as well as in the superficial structures of the adult organism, but 
also in the internal organs after post-mortem dissection. 
The reporter expression pattern described here highlights an almost ubiquitous 
activation of Yap/Taz signaling during early embryonic development, with a stronger 
signal in the proliferating and undifferentiated tail bud mesenchyme (Figure 4.12). This 
likely reflects the general role first discovered for YAP/TAZ as nuclear transducers of 
the Hippo pathway, regarding the promotion of cell proliferation and organ growth 
during development. The activation of the Hippo pathway and the consequent silencing 
of YAP/TAZ activity, on the contrary, is responsible for the growth arrest when the 
organs reach their appropriate size. In the adult organism, in fact, YAP/TAZ expression 
is strongly restricted, being enriched in the stem/progenitor cells niches (Ramos and 
Camargo, 2012). Consistently with this, the Hsa.CTGF-based zebrafish reporter is 
largely silenced in the adult fish with respect to the embryonic and larval development. 
However, further investigation is needed to see if these zebrafish lines report a specific 
activation in the anatomical compartments containing stem/progenitor cells. 
A highly positive organ in the adult is represented by the ovary, where the reporter 
protein is present in the nuclei of the oocytes. The presence of Yap/Taz target genes in 
the eggs might contribute to the very first biological events occurring in the embryo. 
The other tissues and organs in which a reporter signal was observed in the adult are the 
lens, the heart and the endothelium. While in the lens the presence of the reporter 
protein could be simply due to the almost absent protein turnover of the lens cells 
(Stewart et al., 2013), the persistent activity of Yap/Taz in the cardiovascular system 
could suggest an important role of this signaling in the maintenance of cardiac and 
vascular functions. A fascinating possibility is that Yap/Taz activity there, and in the 
cardiac ventricle in particular, could be sustained by the continuous mechanical stress 
which the cells are subjected to. 
By looking in more detail at the reporter activation throughout the development, 
some reporter-expressing anatomical districts come out over the others, mainly the lens, 
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the pharyngeal arches, the heart, the pectoral fin and the otic vesicle. Along the trunk, 
Yap/Taz activation was detected in all the structures recognizable of the region, with a 
strong reporter expression particularly in the floorplate. Interestingly, the developing 
nervous system appears as the least reporter-expressing domain. A very weak signal is 
detected in the neural tube, while in the brain the reporter is almost completely off. 
Intriguing, however, is the Yap/Taz activity revealed by the reporter expression in the 
MHB region (although the neural nature of the fluorescent cells remains to be 
determined) and in the rhombencephalic region, where six stripes of fluorescent cells 
seam to follow the metameric organization of the rhombomeres (Figure 4.13 C). As 
already mentioned, many of these districts are novel domains of Yap/Taz activity first 
revealed in vivo by the Hsa.CTGF-based zebrafish reporter lines here described. Among 
these, the endothelium in particular attracted our attention, since a general and sustained 
activity of the reporter is detected in this tissue from when it starts to develop till 
adulthood. Importantly, all these reporter-expressing domains might suggest a role of 
Yap/Taz signaling in the development of tissues and organs or in their maintenance in 
adulthood, which is worth investigating. 
 
Despite the general silencing of YAP/TAZ activity reported in the adult organism, a 
number of studies are demonstrating how the reactivation of YAP/TAZ signaling plays 
an instrumental and apparently general role in the regeneration. This activation of 
Yap/Taz was reported by the Tg(Hsa.CTGF:nlsmCherry) line in the well-established 
regeneration models represented by the larval fin primordia and adult epimorphic fin 
regeneration after amputation. We showed that the Yap/Taz biosensor zebrafish is able 
to report the expected activation of the signaling pathway in these regenerative 
processes, opening wide possibilities to study the details of Yap/Taz involvement in 
regeneration. The availability of such a reporter, coupled to reporters for other 
signalings implicated in the regeneration (first of all the Wnt/β-catenin pathway) and to 
the advantages of the zebrafish model, will enable powerful in vivo imaging of different 
regenerative processes and analysis of the relationships among the different molecular 
players. 
Furthermore, cancer could be seen as the corresponding pathological side of the coin, 
that as well in many cases requires the reactivation, although aberrant and out of 
control, of YAP/TAZ. An exciting application of the Hsa.CTGF-based zebrafish 
reporter lines is therefore in the study of Yap/Taz role in tumorigenesis, by the use of 
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zebrafish tumor models, which permit also to monitor in real time processes as tumor 
growth and metastasis. 
 
 
5.3 Yap/Taz zebrafish reporter as a tool for drug screening 
 
Different chemical compounds were used on the Hsa.CTGF-based reporter to 
demonstrate its regulation by the Wnt/β-catenin pathway. Treatments with IWR-1, 
XAV939 and BIO drugs showed how the fluorescent reporter signal can be modulated 
by the chemical activation or inhibition of molecular pathways. From here, it appears 
evident how such a living reporter line could be exploited as a versatile platform for the 
discovery, screening and validation of novel drugs acting as agonists or antagonists of 
YAP/TAZ signaling, as already proposed for other zebrafish reporter lines (Weger et 
al., 2012; Moro et al., 2012; Moro et al., 2013). The big advantages of the use of a 
zebrafish reporter line are represented by the possibility to perform large-scale chemical 
screens with automated systems (Walker et al., 2012), the easy delivery of orally active 
drugs directly added to the fish water and, above all, the analysis of the pharmacological 
effect on a molecular pathway in vivo in a vertebrate organism. 
The need of safe and effective drugs able to modulate YAP/TAZ activity is 
particularly relevant for a scientifically young signaling pathway like this, which has a 
strong impact on development, cancer and regeneration. In fact, both agonists and 
antagonists of YAP/TAZ signaling could be therapeutically relevant: contrasting 
YAP/TAZ activity might help in combatting cancer; the possibility to tune them at will 
might improve tissue regeneration. 
 
 
5.4 Wnt/β-catenin pathway regulates Yap/Taz activity 
during development 
 
Very recently a model was depicted, that revolutionizes our vision on YAP/TAZ 
activity regulation and its relationship with other signaling pathways. YAP and TAZ 
were demonstrated to be integral component of the β-catenin destruction complex and 
to be regulated by this complex in response to a Wnt signal similarly to β-catenin. 
YAP/TAZ represent therefore a transcriptional branch of the Wnt pathway, mediating a 
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significant fraction of Wnt biological responses, as demonstrated in cultured cells and in 
particular conditions in mice, such as in the APC/YAP/TAZ triple knockout in the 
intestine (Azzolin et al., 2012; Azzolin et al., 2014). 
The zebrafish Hsa.CTGF-based reporter permitted to show in a living organism 
during development the regulation that the Wnt/β-catenin pathway exerts on Yap/Taz 
activity. As expected from the model, the up- or downregulation of the β-catenin 
destruction complex activity should result respectively in an up- or downregulation of 
both β-catenin and Yap/Taz transcriptional outputs. Our results in terms of variations of 
the reporter signal, after either genetic or pharmacological modulation of the complex 
activity, are in perfect accordance with the model. This confirms that the regulation of 
Yap/Taz activity mediated by the β-catenin destruction complex may function also in 
vivo during development. Moreover, in the same Yap/Taz zebrafish reporter we tested 
also the importance of the phosphorylation of β-catenin to drive Taz to degradation. 
Consistently, inhibition of β-catenin phosphorylation by treatment with BIO resulted in 
an increased expression of the reporter, readout of Yap/Taz activity. 
It is worth noting, however, that all the modulations of Yap/Taz activity observed 
with the reporter zebrafish by acting on the Wnt/β-catenin pathway, although 
significant, were never particularly robust. As a comparison, the same genetic and 
pharmacological tools are much stronger when used on a Wnt/β-catenin reporter fish 
(Moro et al., 2012). This cannot be due to the limited ability of the Hsa.CTGF-based 
reporter to sense Yap/Taz activity variations, since mild alterations of Yap/Taz 
signaling, as performed for example with Yap/Taz morpholinos or TAZ-4SA mRNA 
injections, were shown to strongly modulate the reporter signal. A possible explanation 
could be that, in the complexity of a vertebrate organism such as zebrafish, the control 
of Yap/Taz activity is very tight and finely tuned by the intersection of many regulatory 
networks. Within this view, the Wnt/β-catenin pathway is only one modality the cells 
have to regulate Yap/Taz activity, together with the Hippo pathway and the other 
known or still undiscovered molecular actors. On the other hand, the morpholino oligos 
and the mRNAs used act directly on Yap/Taz or downstream, at the level of the 
Yap/Taz/Tead-mediated transcription, and are so expected to have a more powerful 
impact on the reporter signal. 
What shown here regarding the Wnt/β-catenin pathway can be extended to the study 
of other possible crosstalks among Yap/Taz and other signaling pathways involved in 
vertebrate development and in cancer. Firstly, for instance, we could see if also the 
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reverse regulation, i.e. the inhibitory action of cytoplasmic YAP/TAZ on β-catenin 
activity (Azzolin et al., 2014), can be reported in vivo in zebrafish, in this case by using 
a Wnt/β-catenin reporter line. Thanks to living biosensor fish like the Yap/Taz reporter 
described here, relationships in space and time of activation of different signalings can 
be investigated in vivo also in many pathological contexts, by using the variety of 
zebrafish models of human diseases becoming available. 
 
 
5.5 A role for Yap/Taz in angiogenesis 
 
The general and sustained reporter activity we observed in the endothelium during 
embryogenesis suggested a possible functional involvement of Yap/Taz signaling in 
developmental angiogenesis. In fact, we showed that Yap/Taz knockdown impaired 
ISVs angiogenesis, while Yap/Taz overactivation caused a cell-autonomous aberrant 
sprouting from the ISVs, proposing a pro-angiogenic role of Yap/Taz transcriptional 
activity. 
Only incomplete and indirect associations between YAP/TAZ signaling and 
angiogenesis are present in the literature. Very recent works are unraveling now a link 
between YAP/TAZ and pathways involved in angiogenesis, such as the Wnt/β-catenin, 
the hypoxia response, the Angiomotins and the mevalonate/Rho GTPases signalings. 
 
5.5.1 YAP/TAZ, Wnt/β-catenin pathway and angiogenesis 
 
The tight link existing between the Wnt/β-catenin pathway and YAP/TAZ might 
have an interesting significance also in angiogenesis. The pro-angiogenic role of Wnt 
signaling, carried on by β-catenin-mediated transcription of genes such as VEGF (Choi 
et al., 2012), could be coherently supported by YAP/TAZ-mediated transcription, at 
least during development, where both Wnt/β-catenin and YAP/TAZ signalings are 
active in the vasculature. In fact, Wnt-mediated inhibition of the β-catenin destruction 
complex results in both β-catenin and YAP/TAZ nuclear translocation and 
transcriptional activation (Azzolin et al., 2014), as we also evidenced in vivo by using 
the Hsa.CTGF-based reporter. This means that Wnt signals could impact on 
angiogenesis by co-regulating two sets of target genes. Within this hypothesis, the 
Hippo pathway might also have a double effect on angiogenesis. Indeed, the activation 
of the Hippo pathway, by promoting YAP/TAZ cytoplasmic retention, thus inhibiting 
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their nuclear activity, inhibits also β-catenin, whose degradation requires the presence of 
YAP/TAZ in the complex (Azzolin et al., 2014). 
 
5.5.2 YAP/TAZ, hypoxia and angiogenesis 
 
Even if in different biological conditions, both YAP and TAZ were found to 
associate with HIF1α within the nucleus and to promote HIF1α transcriptional activity, 
included the expression of key pro-angiogenic genes such as VEGF. Functionally, YAP 
knockdown in a breast cancer xenograft mouse model led to a reduced microvessel 
density due to an impairment in HIF1α activity (Ma et al., 2014; Bendinelli et al., 2013). 
Thus, the delay in the ISVs growth we described after morpholino-mediated Yap/Taz 
knockdown could be explained by the YAP/TAZ action on HIF1α accumulation and its 
pro-angiogenic functions. Oppositely, the aberrant angiogenesis obtained by forced 
activation of Yap/Taz could be due to an increased HIF1α-driven transcription 
occurring in concomitance to the increased Yap/Taz/Tead-driven transcription 
highlighted by the Hsa.CTGF-based reporter. 
However, the same phenotype seen after injection of the non-phosphorylatable 
versions of YAP and TAZ (YAP-5SA and TAZ-4SA) was reported also after injection 
of the constitutively active version of TEAD transcription factor (TEAD-VP16). But 
TEAD is not known to bind HIF1α transcriptional complex as done by YAP and TAZ, 
meaning that the vessel sprouting-promoting activity we observed in this case cannot be 
due to HIF1α-mediated transcription, but it should be triggered by the transcriptional 
activity of Yap/Taz/Tead. Hence, both the effects of Yap/Taz morpholinos and YAP-
5SA or TAZ-4SA mRNAs cannot be ascribed totally to the regulation exerted by 
Yap/Taz on HIF1α activity in the nucleus. On the contrary, it is likely that the vascular 
phenotype is due mostly to Yap/Taz transcriptional activity, since TEAD-VP16 and 
YAP-5SA or TAZ-4SA were equally effective in causing the phenotype. This is also 
consistent with the strong Yap/Taz reporter signal in the endothelium, which suggested 
indeed a role for the transcriptional activity of Yap/Taz in embryonic angiogenesis. 
Now, if we consider the picture delineated by Ma et al. (2014) and Bendinelli et al. 
(2013) in which, under hypoxia, increased levels of both YAP and TAZ were registered 
in the nucleus, an intriguing scenario opens. The hypoxia response pathway promotes 
HIF1α nuclear accumulation and activity, which lead to a pro-angiogenic response. In 
addition, at the same time, hypoxia promotes also YAP/TAZ nuclear accumulation and 
activity, which, on one hand, sustain HIF1α-mediated transcription, on the other hand 
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trigger YAP/TAZ/TEAD-mediated transcription, that might also lead to a pro-
angiogenic response, in accordance with our observation in zebrafish. Therefore, the 
road bringing hypoxia to angiogenesis might be mediated by a double transcriptional 
activation and rely not only on HIF1α target genes but also on YAP/TAZ target genes. 
Of course, further studies are needed first to clarify the impact of YAP/TAZ 
transcriptional activity on angiogenesis and then to explore the crosstalk between HIF1α 
and YAP/TAZ within the hypoxia response pathway, together with the mechanisms and 
the target genes effectively supporting angiogenesis. 
 
5.5.3 YAP/TAZ, Angiomotins and angiogenesis 
 
Other important players in angiogenesis are the Angiomotins, whose interaction with 
the Hippo/YAP/TAZ pathway is tight even if with controversial outcomes. Our findings 
about the requirement of Yap/Taz for the proper ISVs growth and their vessel 
sprouting-promoting capacity can fit well with the proposed models of AMOT crosstalk 
with the Hippo/YAP pathway (Dai et al., 2013; Yi et al., 2013). It was shown, in fact, 
that the Hippo pathway activation results in LATS-mediated AMOT phosphorylation, 
disruption of AMOT binding to F-actin and subsequent decrease of F-actin stress fibers 
and focal adhesion, that finally leads to inhibition of angiogenesis (Dai et al., 2013). 
Thus, given the positive role of YAP/TAZ toward angiogenesis that we proposed, the 
Hippo-mediated inhibition of angiogenesis via AMOT phosphorylation would be 
coherent with the Hippo-mediated inhibition of angiogenesis via YAP phosphorylation 
and inhibition of YAP/TAZ-driven transcription. This point of view presents LATS as a 
potent player in angiogenesis inhibition, realized both by detaching AMOT from F-actin 
and by excluding YAP from the nucleus.  Moreover, AMOT phosphorylation promotes 
AMOT-YAP association, inhibiting YAP activity (Dai et al., 2013). This, again, would 
reinforce the negative regulation of angiogenesis exerted by the Hippo pathway. 
AMOT-YAP association, however, was also shown to prevent YAP phosphorylation 
by LATS and promote YAP nuclear translocation and target genes transcription in liver-
specific Amot knockout mice (Yi et al., 2013). This discrepancy could be ascribed to the 
phosphorylation status of AMOT, which, when phosphorylated by LATS, inhibits YAP, 
and when not behaves in the opposite way. In such a context, the reduction in YAP 
nuclear activity observed in Amot knockout background could couple the impairment in 
angiogenesis due to the lack of AMOT with that derived from the downregulation of 
YAP-mediated transcription. 
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Anyway, new studies with different experimental setups are necessary to clarify the 
interaction between AMOT and YAP and in particular its biological significance in 
vivo. 
 
5.5.4 YAP/TAZ, mevalonate/Rho GTPases signaling and angiogenesis 
 
Similarly to the Wnt/β-catenin and the hypoxia response pathways, the 
mevalonate/Rho GTPases signaling could represent another pathway regulating 
angiogenesis through two different mechanisms, in light of the pro-angiogenic role of 
YAP/TAZ suggested by our observations in the zebrafish model. The mevalonate 
pathway, in fact, sustains cell locomotion and angiogenesis through FPP-mediated Ras 
and GGPP-mediated Rho cytoplasm-to-membrane translocation and activation. In 
consequence of this, Rho was demonstrated to inhibit YAP/TAZ phosphorylation, thus 
leading to their nuclear accumulation and activity. Therefore, the mevalonate pathway 
might promote angiogenesis by activating Ras and Rho but also by stimulating 
YAP/TAZ transcriptional activity. Oppositely, the inhibition of the mevalonate pathway 
by treatment with drugs such as the statins, might block the angiogenesis by silencing 
both the responses. 
 
From this analysis, it appears evident how a possible role of YAP/TAZ 
transcriptional activity in triggering angiogenesis could be interesting and place 
Hippo/YAP/TAZ signaling among a complex network of pathways converging on 
angiogenesis through different roads. Furthermore, if this novel role of YAP/TAZ will 
be confirmed and shown in different biological contexts, it will have a strong impact in 
YAP/TAZ biology, especially in the cancer field. In fact, despite the relevance of 
YAP/TAZ in cancerogenesis is undeniable, it is not known if the aberrant activation of 
YAP/TAZ in the progression toward malignancy is responsible also for the 
angiogenesis necessary to sustain tumor growth. 
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